subject: UMLS:C4042170

object_name: plasma cell myeloma


subject: UMLS:C4042170

object_name: sinus histiocytosis with massive lymphadenopathy

tested_intervention: yes


subject: CHEBI:8871

subject_name: Risperidone

object_name: cocaine abuse


subject: CHEBI:6970

subject_name: Mometasone

object_name: Atopic rhinitis


subject: CHEBI:194548

subject_name: Racepinephrine

object_name: Dysphagia


subject: CHEBI:194548

object_name: Dysphagia, CTCAE


subject: CHEBI:194548

object_name: voice disorders


subject: CHEBI:194548

object_name: Dysphonia


subject: CHEBI:194548

object_name: Hoarse voice


subject: CHEBI:4466

subject_name: Dexmedetomidine

object_name: Anxiety and fear

tested_intervention: unsure


subject: UNII:7N8K34P2XH

subject_name: Detomidine


subject: UMLS:C5706326

subject_name: SPR 001

object_name: adrenogenital syndrome


subject: UMLS:C5706326

object_name: congenital adrenal hyperplasia


subject: UNII:GKF8S4C432

subject_name: Anlotinib

object_name: Childhood Soft Tissue Sarcoma


subject: UNII:GKF8S4C432

object_name: Adult Soft Tissue Sarcoma


subject: UNII:GKF8S4C432

object_name: sarcoma


subject: UNII:GKF8S4C432

object_name: Non-Metastatic Childhood Soft Tissue Sarcoma


subject: UNII:GKF8S4C432

object_name: soft tissue sarcoma


subject: GTOPDB:12989

subject_name: toripalimab


subject: GTOPDB:12989


subject: GTOPDB:12989


subject: GTOPDB:12989


subject: GTOPDB:12989


subject: UNII:8JXN261VVA


subject: UNII:8JXN261VVA


subject: UNII:8JXN261VVA


subject: UNII:8JXN261VVA


subject: UNII:8JXN261VVA


subject: UMLS:C4329337

subject_name: TAB 001


subject: UMLS:C4329337


subject: UMLS:C4329337


subject: UMLS:C4329337


subject: UMLS:C4329337


subject: GTOPDB:13085

subject_name: adebrelimab

object_name: esophageal squamous cell carcinoma


subject: UNII:1XBY50W1OX

subject_name: ADEBRELIMAB


subject: UMLS:C4725109


subject: CHEBI:31898

subject_name: Nedaplatin


subject: CHEMBL.COMPOUND:CHEMBL3137685

subject_name: NEDAPLATIN


subject: UMLS:C5207052

subject_name: Paclitaxel Albumin


subject: CHEBI:6888

subject_name: Methylprednisolone

object_name: plasma cell myeloma


subject: GTOPDB:8323

subject_name: monalizumab

object_name: hematopoietic and lymphoid system neoplasm


subject: UNII:3ZXZ2V0588


subject: UMLS:C3896730


subject: CHEBI:31898

object_name: neoplasm of esophagus


subject: CHEMBL.COMPOUND:CHEMBL3137685


subject: GTOPDB:7986

subject_name: rilotumumab

object_name: Stomach cancer


subject: GTOPDB:7986

object_name: gastric cancer


subject: UNII:51WEW898IJ


subject: UNII:51WEW898IJ


subject: UMLS:C1879711

subject_name: AMG 102


subject: UMLS:C1879711


subject: UMLS:C5854345

object_name: Hepatic impairment


subject: CHEBI:16480

subject_name: Nitric Oxide

object_name: Coronavinae infectious disease


subject: CHEBI:16480

object_name: severe acute respiratory syndrome


subject: PUBCHEM.COMPOUND:58008990

subject_name: Duvelisib

object_name: B-cell chronic lymphocytic leukemia


subject: UNII:O43472U9X8

subject_name: Obinutuzumab


subject: CHEMBL.COMPOUND:CHEMBL4594594

subject_name: ITEPEKIMAB

object_name: chronic rhinosinusitis with nasal polyps


subject: UMLS:C5421034

subject_name: itepekimab


subject: UMLS:C5565157


subject: CHEBI:63610

subject_name: Misoprostol

object_name: Birthing Labor


subject: UNII:9G6U5L461Q

subject_name: Icotinib

object_name: squamous cell lung carcinoma


subject: UNII:D7RD81HE4W

subject_name: thymoglobulin

object_name: kidney failure


subject: UMLS:C0359156

subject_name: Thymoglobulin


subject: CHEBI:66910

subject_name: Axitinib

object_name: Adult Gliosarcoma


subject: CHEBI:66910

object_name: gliosarcoma


subject: CHEBI:66910

object_name: Childhood Gliosarcoma


subject: CHEBI:66910

object_name: Recurrent Childhood Glioblastoma


subject: CHEBI:66910

object_name: Recurrent Glioblastoma


subject: CHEBI:134735

subject_name: Omarigliptin

object_name: type 2 diabetes mellitus


subject: CHEMBL.COMPOUND:CHEMBL4298190

subject_name: OMIDUBICEL

object_name: hematopoietic and lymphoid system neoplasm


subject: UNII:M3H4D91AY5

subject_name: Rencofilstat


subject: UNII:M3H4D91AY5

object_name: Liver Fibrosis


subject: UNII:M3H4D91AY5

object_name: metabolic dysfunction-associated steatotic liver disease


subject: UMLS:C4287682

subject_name: c-Met Inhibitor HS-10241

object_name: non-small cell lung carcinoma


subject: CHEBI:16899

subject_name: Mannitol

object_name: no feeling or sensation of skin


subject: CHEBI:16899

object_name: Sensory Loss


subject: UNII:J303A6U9Y6

subject_name: ENCLOMIPHENE CITRATE

object_name: hypogonadotropic hypogonadism


subject: UMLS:C0086214

subject_name: Enclomiphene Citrate


subject: CHEBI:47381

subject_name: Diclofenac

object_name: migraine


subject: CHEBI:47381

object_name: migraine with or without aura, susceptibility to, 1


subject: CHEBI:5118

subject_name: Fluoxetine

object_name: pulmonary hypertension, primary, 1


subject: CHEBI:5118

object_name: pulmonary hypertension


subject: CHEBI:5118

object_name: idiopathic pulmonary arterial hypertension


subject: CHEBI:5118

object_name: pulmonary arterial hypertension


subject: CHEBI:175901

subject_name: Gemcitabine

object_name: nasopharyngeal carcinoma


subject: CHEBI:175901

object_name: nasopharyngeal carcinoma, susceptibility to, 1


subject: CHEBI:44915

subject_name: Propofol

object_name: brain neoplasm


subject: CHEBI:9130

subject_name: Sevoflurane


subject: CHEMBL.COMPOUND:CHEMBL4298001

subject_name: CETRELIMAB

object_name: bladder tumor


subject: UMLS:C4329336


subject: UMLS:C4727717

subject_name: TAR 200


subject: CHEBI:6888

subject_name: Methylprednisolone

object_name: intervertebral disk degenerative disorder


subject: CHEBI:6888

object_name: lumbar disk degenerative disorder


subject: CHEBI:6888

object_name: Herniation of nucleus pulposus


subject: CHEBI:6888

object_name: Myeloradiculopathy


subject: CHEBI:6888

object_name: radiculopathy


subject: CHEBI:6888

object_name: bone marrow disorder


subject: CHEBI:6888

object_name: spinal cord disorder


subject: CHEBI:6888

object_name: Myelopathy


subject: CHEBI:6888

object_name: stricture


subject: CHEBI:6888

object_name: spondylosis


subject: UNII:DPT0O3T46P

subject_name: Pembrolizumab

object_name: Locally Advanced Oropharyngeal Carcinoma


subject: UNII:DPT0O3T46P

object_name: HPV-related carcinoma


subject: UNII:DPT0O3T46P

object_name: Stage IVB Oropharyngeal (p16-Negative) Carcinoma AJCC v8


subject: UNII:DPT0O3T46P

object_name: Stage IVA Oropharyngeal (p16-Negative) Carcinoma AJCC v8


subject: UNII:DPT0O3T46P

object_name: Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8


subject: GTOPDB:9758

subject_name: camrelizumab

object_name: colorectal cancer


subject: GTOPDB:9758

object_name: colorectal carcinoma


subject: GTOPDB:9758

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: UNII:73096E137E


subject: UNII:73096E137E


subject: UNII:73096E137E


subject: UMLS:C4085979


subject: UMLS:C4085979


subject: UMLS:C4085979


subject: UNII:TWF0ML1CK8

subject_name: Fluzoparib


subject: UNII:TWF0ML1CK8


subject: UNII:TWF0ML1CK8


subject: CHEBI:40279

subject_name: Allopurinol

object_name: leukemia


subject: CHEBI:40279

object_name: childhood leukemia


subject: CHEBI:32660

subject_name: asparaginase


subject: CHEBI:32660


subject: CHEBI:15640

subject_name: Leucovorin


subject: CHEBI:15640


subject: CHEBI:8382

subject_name: Prednisone


subject: CHEBI:8382


subject: UNII:N19A0T0E5J

subject_name: Parathyroid hormone

object_name: hypoparathyroidism


subject: UNII:N19A0T0E5J

object_name: Hypoparathyroidism, CTCAE


subject: UMLS:C4255609

subject_name: Parathormone (human recombinant)


subject: UMLS:C4255609


subject: CHEBI:37810

subject_name: octadecatetraenoic acid


subject: CHEBI:37810


subject: CHEBI:7773

subject_name: Ondansetron

object_name: cholecystitis


subject: CHEBI:7773

object_name: Cholecystitis, CTCAE 3.0


subject: CHEBI:7773

object_name: Cholecystitis, CTCAE 5.0


subject: PUBCHEM.COMPOUND:73005958

subject_name: Carfilzomib

object_name: lymphoma, non-Hodgkin, familial


subject: PUBCHEM.COMPOUND:73005958

object_name: non-Hodgkin lymphoma


subject: PUBCHEM.COMPOUND:73005958

object_name: Hodgkin Disease


subject: UMLS:C1709429


subject: UMLS:C1709429


subject: UMLS:C1709429


subject: UMLS:C3641791


subject: UMLS:C3641791


subject: UMLS:C3641791


subject: CHEBI:146178

subject_name: RACEMETHORPHAN

object_name: trigeminal neuralgia


subject: CHEBI:146178

object_name: cranial neuralgia


subject: CHEBI:146178

object_name: facial neuralgia


subject: CHEBI:146176

subject_name: levomethorphan


subject: CHEBI:146176


subject: CHEBI:146176


subject: CHEBI:4470

subject_name: Dextromethorphan


subject: CHEBI:4470


subject: CHEBI:4470


subject: UNII:3K5H4TX2KP

subject_name: COBOLIMAB

object_name: non-small cell lung carcinoma


subject: UMLS:C4287698

subject_name: Cobolimab


subject: UNII:P0GVQ9A4S5

subject_name: Dostarlimab


subject: UMLS:C4287697


subject: UNII:68AYS9A614

subject_name: CEDIRANIB MALEATE

object_name: malignant epithelioid mesothelioma


subject: UNII:68AYS9A614

object_name: malignant mesothelioma


subject: UNII:68AYS9A614

object_name: Mesothelioma malignant recurrent


subject: UNII:68AYS9A614

object_name: sarcomatoid mesothelioma


subject: UMLS:C2711999

subject_name: cediranib maleate


subject: UMLS:C2711999


subject: UMLS:C2711999


subject: UMLS:C2711999


subject: UMLS:C5979813

object_name: chronic idiopathic urticaria


subject: CHEBI:149504

object_name: mood (physical finding)


subject: CHEBI:6541

subject_name: Losartan


subject: CHEBI:51348

subject_name: tetraphene


subject: CHEBI:29022

subject_name: N-benzyladenine


subject: PUBCHEM.COMPOUND:53477793


subject: CHEBI:32594

subject_name: barium atom


subject: CHEBI:3087

subject_name: Betulinic Acid


subject: CHEBI:37136


subject: DRUGBANK:DB12481

subject_name: Barium


subject: MESH:C000709231

object_name: Myelodysplasia


subject: MESH:C000709231

object_name: acute myeloid leukemia


subject: CHEBI:75929

object_name: Tourette syndrome


subject: CHEBI:40009

subject_name: Cycloserine


subject: UMLS:C1512058

subject_name: Doxorubin

object_name: liver carcinoma


subject: UMLS:C1512058

object_name: Klatskin Tumor


subject: UNII:DPT0O3T46P

subject_name: Pembrolizumab

object_name: colon adenocarcinoma


subject: CHEBI:17997

subject_name: Nitrogen

object_name: Coronavinae infectious disease


subject: CHEBI:17997

object_name: respiratory tract infectious disorder


subject: UMLS:C1510693

object_name: malaria


subject: UMLS:C5706561

subject_name: Actinium Ac 225 DOTATATE RYZ101

object_name: Carcinoma breast stage IV


subject: UMLS:C5706561

object_name: Her2-receptor negative breast cancer


subject: UMLS:C5706561

object_name: estrogen-receptor positive breast cancer


subject: UMLS:C5706561

object_name: Advanced breast cancer


subject: UNII:A14FB57V1D

subject_name: GLYCOPYRRONIUM

object_name: Chronic obstructive pulmonary disease of horses


subject: CHEBI:94449

subject_name: Glycopyrronium


subject: CHEBI:119915

subject_name: Fentanyl

object_name: abscess


subject: CHEBI:68579

subject_name: Rivaroxaban

object_name: Cirrhosis


subject: CHEBI:68579

object_name: liver cirrhosis


subject: UNII:07HQ1TJ4JE

subject_name: Pritelivir

object_name: herpes simplex


subject: CHEBI:89324

subject_name: 24,25-Dihydroxyvitamin D

object_name: Prediabetes


subject: UMLS:C3714503

subject_name: Vitamin D Drug Class


subject: UNII:9VU1KI44GP

subject_name: VITAMIN D


subject: UMLS:C2936842

subject_name: Vitamin D [EPC]


subject: CHEBI:27300

subject_name: Ergocalciferol


subject: UMLS:C3537249

subject_name: D Vitamin


subject: CHEBI:74705

subject_name: Met-Leu

object_name: Periorbital hyperpigmentation


subject: PR:000009425

subject_name: killer cell lectin-like receptor subfamily F member 1


subject: PR:000016318

subject_name: thrombopoietin


subject: CHEBI:28918

subject_name: Epinephrine

object_name: Post-ERCP acute pancreatitis


subject: UMLS:C2346820

object_name: metastatic melanoma


subject: CHEBI:135918

subject_name: Tucidinostat

object_name: Neoplasms, Experimental


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: CHEBI:64816


subject: CHEBI:91872


subject: CHEBI:28748

subject_name: Doxorubicin


subject: CHEBI:4911

subject_name: Etoposide


subject: CHEBI:8382

subject_name: Prednisone


subject: CHEBI:143658


subject: CHEBI:28445

subject_name: vincristine


subject: CHEBI:17650

subject_name: Hydrocortisone

object_name: skin disorder


subject: CHEBI:61049

subject_name: Tacrolimus


subject: CHEBI:192614

subject_name: Homosildenafil

object_name: emphysema


subject: UNII:L6WO34R9YG

subject_name: N-Desmethyl sildenafil (UK-103,320)


subject: PUBCHEM.COMPOUND:131769997

subject_name: Hydromorphone 3-beta-O-glucuronide


subject: CHEBI:183660

subject_name: Acetildenafil


subject: UNII:80X7B1F6NW

subject_name: LODENAFIL


subject: CHEBI:25681

subject_name: Omega-3 fatty acids

object_name: Mastalgia


subject: CHEBI:25681

object_name: BREAST PAIN FEMALE


subject: UMLS:C0592257

subject_name: Vita-E


subject: UMLS:C0592257


subject: GTOPDB:13342

subject_name: obiltoxaximab

object_name: anthrax disease


subject: GTOPDB:13342

object_name: bacterial infectious disease


subject: UNII:29Z5DNL48C

subject_name: Obiltoxaximab


subject: UNII:29Z5DNL48C


subject: CHEBI:135005

subject_name: Milnacipran

object_name: Back Pain, CTCAE 5.0


subject: CHEBI:135005

object_name: Back pain


subject: CHEBI:135005

object_name: Back Pain, CTCAE 3.0


subject: CHEBI:44915

subject_name: Propofol

object_name: primary interstitial lung disease specific to childhood


subject: CHEBI:44915

object_name: interstitial lung disease specific to childhood


subject: CHEBI:174615

object_name: immunodeficiency disease


subject: CHEBI:28901

subject_name: Busulfan


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: PUBCHEM.COMPOUND:3367


subject: CHEBI:63599

subject_name: Fludarabine


subject: CHEBI:168396

subject_name: Mycophenolic acid


subject: CHEBI:8764

subject_name: Mycophenolate mofetil


subject: CHEBI:167450

subject_name: Monomethyl fumarate


subject: CHEBI:61057

subject_name: TACROLIMUS


subject: PUBCHEM.COMPOUND:5372


subject: CHEBI:61049

subject_name: Tacrolimus


subject: PUBCHEM.COMPOUND:53328043

subject_name: Iberdomide

object_name: Plasma cell myeloma refractory


subject: PUBCHEM.COMPOUND:53328043

object_name: plasma cell myeloma


subject: UNII:4W3KFI3TN3

subject_name: Talquetamab


subject: UMLS:C4687984

subject_name: talquetamab


subject: CHEBI:85078

subject_name: Dapagliflozin

object_name: cystinuria


subject: CHEBI:93775

subject_name: Amethopterin

object_name: gestational trophoblastic neoplasm


subject: CHEBI:50681


subject: CHEBI:44185

subject_name: Methotrexate


subject: PUBCHEM.COMPOUND:24993045

subject_name: Finerenone

object_name: diabetic kidney disease


subject: UMLS:C3529192


subject: UNII:PQX0D8J21J

subject_name: Cetuximab

object_name: rectal neoplasm


subject: UMLS:C0879636

subject_name: IMC C225


subject: CHEBI:8988


subject: CHEBI:80630

subject_name: Irinotecan


subject: CHEBI:85994

subject_name: Lenvatinib

object_name: thyroid tumor


subject: CHEBI:85994

object_name: thyroid gland carcinoma


subject: CHEBI:85994

object_name: thyroid cancer


subject: CHEBI:22652

subject_name: Ascorbic acid

object_name: Childhood Anaplastic Oligodendroglioma


subject: CHEBI:22652

object_name: anaplastic oligodendroglioma


subject: CHEBI:22652

object_name: Adult Anaplastic Oligodendroglioma


subject: CHEBI:22652

object_name: Childhood Anaplastic Oligoastrocytoma


subject: CHEBI:22652

object_name: anaplastic oligoastrocytoma


subject: CHEBI:22652

object_name: Grade III Childhood Astrocytoma


subject: CHEBI:22652

object_name: Adult Anaplastic Astrocytoma


subject: CHEBI:22652

object_name: anaplastic astrocytoma


subject: CHEBI:22652

object_name: glioblastoma


subject: CHEBI:22652

object_name: Childhood Glioblastoma


subject: CHEBI:22652

object_name: adult glioblastoma


subject: CHEBI:22652

object_name: Adult Gliosarcoma


subject: CHEBI:22652

object_name: gliosarcoma


subject: CHEBI:22652

object_name: Childhood Gliosarcoma


subject: UMLS:C0919079

subject_name: TEMOZOLOMIDE, ORAL, 5 MG ADMINISTERED


subject: UMLS:C0919079


subject: UMLS:C0919079


subject: UMLS:C0919079


subject: UMLS:C0919079


subject: CHEBI:72564

subject_name: Temozolomide


subject: CHEBI:72564


subject: CHEBI:72564


subject: CHEBI:72564


subject: CHEBI:72564


subject: PUBCHEM.COMPOUND:58008990

subject_name: Duvelisib

object_name: Transformed Follicular Lymphoma to Diffuse Large B-Cell Lymphoma


subject: PUBCHEM.COMPOUND:58008990

object_name: Transformed Small Lymphocytic Lymphoma to Diffuse Large B-Cell Lymphoma


subject: PUBCHEM.COMPOUND:58008990

object_name: Transformed Chronic Lymphocytic Leukemia to Diffuse Large B-Cell Lymphoma


subject: PUBCHEM.COMPOUND:58008990

object_name: Diffuse large B-cell lymphoma recurrent


subject: PUBCHEM.COMPOUND:58008990

object_name: relapsed/refractory diffuse large B-cell lymphoma


subject: CHEBI:231614

subject_name: Nivolumab

object_name: Richter syndrome


subject: CHEBI:231614


subject: CHEBI:231614

object_name: B-cell chronic lymphocytic leukemia


subject: CHEBI:231614


subject: CHEBI:231614


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UNII:6PJC3KPK6S

object_name: melanoma


subject: UMLS:C1541384

subject_name: TLR7 Agonist 852A


subject: UNII:490D9F069T

subject_name: Lanthanum carbonate tetrahydrate

object_name: chronic kidney disease


subject: UNII:490D9F069T

object_name: Chronic uremia


subject: UNII:0M78EU4V9H

subject_name: Lanthanum carbonate


subject: UNII:0M78EU4V9H


subject: UMLS:C1701110

subject_name: Zactima

object_name: Carcinoma breast stage IV


subject: CHEBI:49960

subject_name: Vandetanib


subject: CHEBI:70839

subject_name: Dasatinib

object_name: chronic myelogenous leukemia, BCR-ABL1 positive


subject: CHEBI:190514


subject: CHEBI:49375


subject: UMLS:C5417780

subject_name: KRT 232


subject: UNII:PVI5M0M1GW

subject_name: Filgrastim

object_name: Neck Carcinoma


subject: UNII:PVI5M0M1GW

object_name: head and neck neoplasm


subject: UNII:PVI5M0M1GW

object_name: head and neck cancer


subject: UNII:PVI5M0M1GW


subject: PR:000005932

subject_name: granulocyte colony-stimulating factor


subject: PR:000005932


subject: PR:000005932


subject: PR:000005932


subject: CHEBI:39585

subject_name: Carbidopa

object_name: cancer


subject: CHEBI:39585

object_name: neoplasm


subject: PUBCHEM.COMPOUND:521372

subject_name: Cannabidiol


subject: PUBCHEM.COMPOUND:521372


subject: CHEBI:50275

subject_name: Esomeprazole

object_name: gastric ulcer


subject: CHEBI:50275

object_name: Gastric Ulcer, CTCAE


subject: CHEBI:168396

subject_name: Mycophenolic acid

object_name: neuromyelitis optica


subject: CHEBI:8764

subject_name: Mycophenolate mofetil


subject: CHEBI:167450

subject_name: Monomethyl fumarate


subject: UNII:YB18NF020M

subject_name: Satralizumab


subject: CHEBI:61057

subject_name: TACROLIMUS

object_name: Liver transplant rejection


subject: CHEBI:61057

object_name: Renal transplant rejection


subject: CHEBI:61057

object_name: Disorder of transplanted kidney


subject: CHEBI:61057

object_name: inherited disease susceptibility


subject: CHEBI:61057

object_name: metabolism medication toxicity


subject: PUBCHEM.COMPOUND:5372


subject: PUBCHEM.COMPOUND:5372


subject: PUBCHEM.COMPOUND:5372


subject: PUBCHEM.COMPOUND:5372


subject: PUBCHEM.COMPOUND:5372


subject: CHEBI:61049

subject_name: Tacrolimus


subject: CHEBI:61049


subject: CHEBI:61049


subject: CHEBI:61049


subject: CHEBI:8499

subject_name: Propranolol

object_name: Physical trauma


subject: CHEBI:8499

object_name: Injury


subject: CHEBI:8499

object_name: Trauma


subject: CHEBI:9757

subject_name: Tropicamide

object_name: retinal detachment


subject: CHEBI:9757

object_name: Retinal Detachment, CTCAE 3.0


subject: CHEBI:9757

object_name: Retinal Detachment, CTCAE 5.0


subject: CHEBI:9757

object_name: macular degeneration


subject: CHEBI:9757

object_name: age-related macular degeneration


subject: CHEBI:9757

object_name: retinitis pigmentosa 30


subject: CHEBI:9757

object_name: Abnormal macular morphology


subject: CHEBI:9757

object_name: Bilateral glaucoma


subject: PUBCHEM.COMPOUND:596

subject_name: Cylocide

object_name: myelodysplastic syndrome with excess blasts


subject: CHEBI:28680

subject_name: Cytarabine


subject: CHEBI:95165


subject: CHEBI:95165

object_name: Adult Acute Myeloid Leukemia with Maturation


subject: CHEBI:95165

object_name: Adult Acute Myeloid Leukemia without Maturation


subject: CHEBI:95165

object_name: Previously Treated Myelodysplastic Syndrome


subject: CHEBI:95165

object_name: acute megakaryoblastic leukemia in adult


subject: CHEBI:95165

object_name: Adult Acute Myelomonocytic Leukemia


subject: CHEBI:95165

object_name: Adult Acute Monoblastic Leukemia


subject: CHEBI:95165

object_name: adult acute monocytic leukemia


subject: CHEBI:95165

object_name: Adult Pure Erythroid Leukemia


subject: CHEBI:95165

object_name: Adult Erythroleukemia


subject: CHEBI:50131

subject_name: Decitabine


subject: CHEBI:50131


subject: CHEBI:50131


subject: CHEBI:50131


subject: CHEBI:50131


subject: CHEBI:50131


subject: CHEBI:50131


subject: CHEBI:50131


subject: CHEBI:50131


subject: CHEBI:50131


subject: PUBCHEM.COMPOUND:3685


subject: PUBCHEM.COMPOUND:3685


subject: PUBCHEM.COMPOUND:3685


subject: PUBCHEM.COMPOUND:3685

object_name: adult acute myeloid leukemia with 11q23 (MLL) abnormalities


subject: PUBCHEM.COMPOUND:3685


subject: PUBCHEM.COMPOUND:3685

object_name: adult acute myeloid leukemia with inv(16)(p13;q22)


subject: PUBCHEM.COMPOUND:3685

object_name: Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11


subject: PUBCHEM.COMPOUND:3685

object_name: acute myeloid leukemia, t(8;21)(q22; q22.1)


subject: PUBCHEM.COMPOUND:3685


subject: PUBCHEM.COMPOUND:3685


subject: PUBCHEM.COMPOUND:3685

object_name: recurrent adult acute myeloid leukemia


subject: PUBCHEM.COMPOUND:3685


subject: PUBCHEM.COMPOUND:3685


subject: PUBCHEM.COMPOUND:3685


subject: PUBCHEM.COMPOUND:3685


subject: CHEBI:42068

subject_name: Idarubicin


subject: CHEBI:42068


subject: CHEBI:42068


subject: CHEBI:42068


subject: CHEBI:42068


subject: CHEBI:42068


subject: CHEBI:42068


subject: CHEBI:42068


subject: CHEBI:42068


subject: CHEBI:42068


subject: CHEBI:42068


subject: CHEBI:42068


subject: CHEBI:42068


subject: CHEBI:42068


subject: CHEBI:42068


subject: CHEBI:31355

subject_name: Carboplatin

object_name: carcinosarcoma of the corpus uteri


subject: CHEBI:31355

object_name: uterine carcinosarcoma


subject: CHEBI:31355

object_name: Stage IA Uterine Sarcoma AJCC v7


subject: CHEBI:31355

object_name: Stage IB Uterine Sarcoma AJCC v7


subject: CHEBI:31355

object_name: Stage IC Uterine Sarcoma AJCC v7


subject: CHEBI:31355

object_name: sarcoma of uterus stage IIa


subject: CHEBI:31355

object_name: Stage IIA Uterine Sarcoma AJCC v7


subject: CHEBI:31355

object_name: Stage IVA Uterine Sarcoma AJCC v7


subject: CHEBI:31355

object_name: Stage IVB Uterine Sarcoma AJCC v7


subject: CHEBI:31355

object_name: sarcoma of uterus stage IIb


subject: CHEBI:31355

object_name: Stage IIB Uterine Sarcoma AJCC v7


subject: CHEBI:31355

object_name: Stage IIIC Uterine Sarcoma AJCC v7


subject: CHEBI:31355

object_name: sarcoma of uterus stage IIIb


subject: CHEBI:31355

object_name: Stage IIIB Uterine Sarcoma AJCC v7


subject: CHEBI:31355

object_name: Stage IIIA Uterine Sarcoma AJCC v7


subject: CHEBI:45863

subject_name: Paclitaxel


subject: CHEBI:45863


subject: CHEBI:45863


subject: CHEBI:45863


subject: CHEBI:45863


subject: CHEBI:45863


subject: CHEBI:45863


subject: CHEBI:45863


subject: CHEBI:45863


subject: CHEBI:45863


subject: CHEBI:45863


subject: CHEBI:45863


subject: CHEBI:45863


subject: CHEBI:45863


subject: CHEBI:45863


subject: CHEBI:77590

subject_name: Armodafinil

object_name: stroke disorder


subject: CHEBI:77590

object_name: cerebrovascular disorder


subject: CHEBI:77590

object_name: Stroke (heart beat)


subject: CHEBI:77590

object_name: Stroke, CTCAE


subject: CHEBI:77590

object_name: Hemiparesis


subject: CHEBI:31859

subject_name: Modafinil


subject: CHEBI:42797

subject_name: Gabapentin

object_name: postherpetic neuralgia


subject: CHEBI:42797

object_name: pulmonary hypertension, neonatal, susceptibility to


subject: CHEBI:42797

object_name: neuropathy


subject: CHEBI:42797

object_name: Nerve Pain


subject: UMLS:C5554607

subject_name: Obrixtamig

object_name: neuroendocrine neoplasm


subject: UNII:B1I77MH6K1

subject_name: Aficamten

object_name: hypertrophic cardiomyopathy


subject: CHEBI:9667

subject_name: Triamcinolone

object_name: thyroid disease


subject: CHEBI:9667

object_name: reported prior thyroid disease (history)


subject: CHEBI:5132

subject_name: Flutamide

object_name: prostate carcinoma


subject: CHEBI:5132

object_name: prostate cancer


subject: CHEBI:5523

subject_name: Goserelin


subject: CHEBI:5523


subject: UMLS:C2729286

subject_name: Injection, docetaxel, 1 mg administered

object_name: gastric neoplasm


subject: UMLS:C5203163

subject_name: Docetaxel Liquid Injection


subject: MESH:C079198

subject_name: S 1 (combination)


subject: CHEBI:100241

subject_name: Ciprofloxacin

object_name: asthma


subject: CHEBI:100241

object_name: bronchiectasis


subject: CHEBI:100241

object_name: Chronic obstructive pulmonary disease of horses


subject: CHEBI:100241

object_name: COPD, severe early onset


subject: CHEBI:100241

object_name: chronic obstructive pulmonary disease


subject: CHEBI:100241

object_name: Pseudomonas aeruginosa infection


subject: CHEBI:100241

object_name: respiratory tract infectious disorder


subject: UNII:X00B0D5O0E

subject_name: PIPERACILLIN


subject: UNII:X00B0D5O0E


subject: UNII:X00B0D5O0E


subject: UNII:X00B0D5O0E


subject: UNII:X00B0D5O0E


subject: UNII:X00B0D5O0E


subject: UNII:X00B0D5O0E


subject: CHEBI:8232

subject_name: Piperacillin


subject: CHEBI:8232


subject: CHEBI:8232


subject: CHEBI:8232


subject: CHEBI:8232


subject: CHEBI:8232


subject: CHEBI:8232


subject: CHEBI:9421

subject_name: Tazobactam


subject: CHEBI:9421


subject: CHEBI:9421


subject: CHEBI:9421


subject: CHEBI:9421


subject: CHEBI:9421


subject: CHEBI:9421


subject: CHEBI:45716

subject_name: Vorinostat

object_name: peritoneum cancer


subject: CHEBI:45716

object_name: ovarian cancer


subject: CHEBI:45716

object_name: ovarian neoplasm


subject: CHEBI:45716

object_name: ovarian carcinoma


subject: CHEBI:45716

object_name: fallopian tube carcinoma


subject: CHEBI:45716

object_name: fallopian tube cancer


subject: CHEBI:68595

subject_name: Telaprevir

object_name: HIV infection


subject: UMLS:C1676059

subject_name: TMC 278

object_name: hepatitis C


subject: CHEBI:68606

subject_name: Rilpivirine


subject: UNII:7805S5HIHX

subject_name: Rolofylline

object_name: heart failure


subject: UNII:7805S5HIHX

object_name: congestive heart failure


subject: UMLS:C0025326

subject_name: Menotropins

object_name: Androgen excess


subject: UMLS:C0360493

subject_name: mixtard insulin

object_name: Gestational diabetes mellitus in pregnancy


subject: CHEBI:6801

subject_name: Metformin


subject: UMLS:C0003364

subject_name: Antihypertensive Agents

object_name: Cardiac complication


subject: CHEBI:35544

subject_name: EC 1.14.99.1 (prostaglandin-endoperoxide synthase) inhibitor

object_name: colorectal cancer


subject: CHEBI:35544

object_name: colorectal carcinoma


subject: CHEBI:35544

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: UMLS:C0085387

subject_name: Cyclooxygenase Inhibitors


subject: UMLS:C0085387


subject: UMLS:C0085387


subject: UMLS:C1440867

subject_name: lactoferrin, bovine

object_name: Mycoses


subject: CHEBI:64312

subject_name: Memantine

object_name: Depressed mood


subject: CHEBI:64312

object_name: Cancer patients and suicide and depression


subject: CHEBI:64312

object_name: Depressed - symptom


subject: CHEBI:64312

object_name: Depression, CTCAE


subject: CHEBI:32129

subject_name: diamminesilver(1+) fluoride

object_name: dental caries


subject: CHEBI:32129

object_name: Dental Caries, CTCAE


subject: RXCUI:2645573

subject_name: diclofenac sodium Injection

object_name: Renal Colic, CTCAE


subject: RXCUI:2645573

object_name: renal colic


subject: UMLS:C4521110

object_name: asthma


subject: CHEBI:73604

subject_name: Lys-Gly

object_name: Tenia solium infection


subject: UNII:5S371K6132

subject_name: Rivoceranib

object_name: dedifferentiated liposarcoma


subject: GTOPDB:9758

subject_name: camrelizumab


subject: UNII:73096E137E


subject: UMLS:C4085979


subject: CHEBI:28748

subject_name: Doxorubicin


subject: UMLS:C4329329

object_name: Stomach cancer


subject: UMLS:C4329329

object_name: gastric cancer


subject: PUBCHEM.COMPOUND:71301229

subject_name: Xelox


subject: PUBCHEM.COMPOUND:71301229


subject: PUBCHEM.COMPOUND:2791

subject_name: Clobetasol propionate

object_name: cataract


subject: PUBCHEM.COMPOUND:2791

object_name: Cataract, CTCAE 3.0


subject: PUBCHEM.COMPOUND:2791

object_name: Cataract, CTCAE 5.0


subject: PUBCHEM.COMPOUND:2791

object_name: cataract on exam (physical finding)


subject: CHEBI:205919

subject_name: Clobetasol


subject: CHEBI:205919


subject: CHEBI:205919


subject: CHEBI:205919


subject: UMLS:C0038416

subject_name: streptodornase / streptokinase

object_name: Acute upper respiratory infection


subject: UMLS:C0038416

object_name: bronchitis


subject: UMLS:C0038416

object_name: Acute bronchitis


subject: CHEBI:45783

subject_name: Imatinib

object_name: Recurrent ovarian cancer


subject: CHEBI:45783

object_name: peritoneum cancer


subject: CHEBI:84040

object_name: Cognitive changes


subject: CHEBI:36002

subject_name: cis-resveratrol


subject: CHEBI:27881

subject_name: resveratrol


subject: CHEBI:37941

subject_name: Clopidogrel

object_name: coronary restenosis


subject: CHEBI:37941

object_name: Chronic total occlusion of coronary artery


subject: CHEBI:37941

object_name: aneurysm


subject: CHEBI:15365

subject_name: Aspirin


subject: CHEBI:15365


subject: CHEBI:15365


subject: UMLS:C3827119

subject_name: Recombinant Human Adenovirus Type 5 H101

object_name: bladder tumor


subject: UMLS:C3827119

object_name: urinary bladder carcinoma


subject: UMLS:C3827119

object_name: urinary bladder cancer


subject: UMLS:C3827119

object_name: childhood bladder carcinoma


subject: GTOPDB:9758


subject: GTOPDB:9758


subject: GTOPDB:9758


subject: GTOPDB:9758


subject: UNII:73096E137E


subject: UNII:73096E137E


subject: UNII:73096E137E


subject: UNII:73096E137E


subject: UMLS:C4085979


subject: UMLS:C4085979


subject: UMLS:C4085979


subject: UMLS:C4085979


subject: UNII:UC95NQ339C

subject_name: BOTULINUM TOXIN

object_name: spastic hemiplegia


subject: UNII:UC95NQ339C

object_name: spastic diplegia


subject: UMLS:C0006055

subject_name: Botulinum Toxins


subject: UMLS:C0006055


subject: UNII:WTT295HSY5

subject_name: Dulaglutide

object_name: metabolic dysfunction-associated steatotic liver disease


subject: UMLS:C2976495


subject: CHEBI:8405

subject_name: Primaquine

object_name: Malaria, Vivax


subject: PUBCHEM.COMPOUND:19784307

subject_name: Bismuth Potassium Citrate

object_name: Helicobacter pylori infection


subject: UMLS:C3252923

subject_name: synflorix

object_name: streptococcal infection


subject: CHEBI:27306

subject_name: vitamin B6

object_name: Reperfusion Injury


subject: CHEBI:27306

object_name: peripheral vascular disease


subject: CHEBI:27306

object_name: peripheral arterial disease


subject: CHEBI:652992

subject_name: doxycycline HCl


subject: CHEBI:652992

object_name: severe acute respiratory syndrome


subject: CHEBI:652992

object_name: Coronavinae infectious disease


subject: PUBCHEM.COMPOUND:54671203

subject_name: doxycycline


subject: PUBCHEM.COMPOUND:54671203


subject: PUBCHEM.COMPOUND:6427057

subject_name: ivermectin


subject: PUBCHEM.COMPOUND:6427057


subject: PUBCHEM.COMPOUND:6427057


subject: CHEBI:6078

subject_name: Ivermectin


subject: CHEBI:6078


subject: CHEBI:6078


subject: CHEBI:71219

subject_name: Pazopanib

object_name: Advanced Soft Tissue Sarcoma


subject: CHEBI:71219

object_name: Metastatic Childhood Soft Tissue Sarcoma


subject: CHEBI:71219

object_name: Metastatic Soft Tissue Sarcoma


subject: CHEBI:71219

object_name: Locally Advanced Soft Tissue Sarcoma


subject: UMLS:C2347328

subject_name: sirolimus protein-bound particles


subject: UMLS:C2347328


subject: UMLS:C2347328


subject: UMLS:C2347328


subject: UNII:AL3G001BI8

subject_name: Ravidasvir

object_name: hepatitis C


subject: UMLS:C4508633

subject_name: ravidasvir


subject: DRUGBANK:DB18333

object_name: hemophilia A


subject: DRUGBANK:DB18333

object_name: von Willebrand disease (hereditary or acquired)


subject: CHEBI:8707

subject_name: Quetiapine

object_name: anxiety disorder


subject: PR:000016600

subject_name: T cell receptor alpha chain constant

object_name: non-Hodgkin lymphoma


subject: UniProtKB:P18004

subject_name: TRAC_ECOLI Protein TraC (sprot)


subject: UniProtKB:P01849

subject_name: TRAC_MOUSE T-cell receptor alpha chain constant (sprot)


subject: UniProtKB:P01848

subject_name: TRAC_HUMAN T cell receptor alpha chain constant (sprot)


subject: PR:000011048

subject_name: nuclear receptor corepressor 2


subject: PR:000024098

subject_name: protein TraC


subject: CHEBI:125354

subject_name: Plerixafor

object_name: Hemoglobin SS disease without crisis


subject: UNII:FU77B4U5Z0

subject_name: Ustekinumab

object_name: Sicca Syndrome


subject: UNII:FU77B4U5Z0

object_name: Primary Sjögren's syndrome


subject: UNII:4EQZ6YO2HI

subject_name: Denosumab

object_name: bone disorder


subject: UMLS:C1530450

subject_name: AMG 162


subject: CHEBI:233453

object_name: Waldenstrom macroglobulinemia


subject: CHEBI:35854

subject_name: Valaciclovir


subject: CHEBI:192614

subject_name: Homosildenafil

object_name: impotence


subject: CHEBI:192614

object_name: Erectile Dysfunction, CTCAE


subject: CHEBI:192614

object_name: Erectile dysfunction


subject: UNII:L6WO34R9YG

subject_name: N-Desmethyl sildenafil (UK-103,320)


subject: UNII:L6WO34R9YG


subject: UNII:L6WO34R9YG


subject: PUBCHEM.COMPOUND:131769997

subject_name: Hydromorphone 3-beta-O-glucuronide


subject: PUBCHEM.COMPOUND:131769997


subject: PUBCHEM.COMPOUND:131769997


subject: CHEBI:183660

subject_name: Acetildenafil


subject: CHEBI:183660


subject: CHEBI:183660


subject: UNII:80X7B1F6NW

subject_name: LODENAFIL


subject: UNII:80X7B1F6NW


subject: UNII:80X7B1F6NW


subject: DRUGBANK:DB16202

subject_name: IONIS-HBVRx

object_name: hepatitis B


subject: DRUGBANK:DB16202

object_name: Chronic hepatitis B atypical


subject: UMLS:C0085297

subject_name: immunoglobulins, intravenous

object_name: chronic obstructive pulmonary disease


subject: DRUGBANK:DB15074

subject_name: Aglatimagene besadenovec

object_name: Recurrent Ependymoma


subject: DRUGBANK:DB15074

object_name: Recurrent Childhood Ependymoma


subject: DRUGBANK:DB15074

object_name: malignant glioma


subject: CHEBI:233453


subject: CHEBI:233453


subject: CHEBI:233453


subject: CHEBI:35854


subject: CHEBI:35854


subject: CHEBI:35854


subject: MESH:C010491

subject_name: neurotropin

object_name: fibromyalgia


subject: UNII:FR50CP1D6W

subject_name: Foliglurax

object_name: Parkinson disease


subject: CHEBI:50634

object_name: retinoschisis


subject: CHEBI:27690

subject_name: Acetazolamide


subject: MESH:D012462

subject_name: Saline Solution, Hypertonic

object_name: septic shock


subject: MESH:D012462

object_name: Sepsis-associated hypotension


subject: CHEBI:135905

subject_name: Terlipressin


subject: CHEBI:91951

object_name: Metastasis


subject: CHEBI:91951

object_name: Metastatic Lesion


subject: PUBCHEM.COMPOUND:17756771

subject_name: Fulvestrant


subject: PUBCHEM.COMPOUND:17756771


subject: CHEBI:85993

subject_name: Palbociclib

object_name: Embolism, Tumor


subject: CHEBI:85993

object_name: Neoplasm Metastasis


subject: CHEBI:85993


subject: CHEBI:85993


subject: UMLS:C4755732

subject_name: Calcipotriol only product in cutaneous dose form

object_name: skin neoplasm


subject: UMLS:C4755732

object_name: skin cancer


subject: UMLS:C4755732

object_name: skin squamous cell carcinoma


subject: UMLS:C4755732

object_name: cutaneous squamous cell carcinoma


subject: UMLS:C4755732

object_name: actinic keratosis


subject: UNII:3OX1DBR75G

subject_name: ULILEDLIMAB

object_name: non-small cell lung carcinoma


subject: UMLS:C5204220


subject: UMLS:C1611320

object_name: brain small vessel disease 3


subject: GTOPDB:8000

subject_name: tabalumab

object_name: plasma cell myeloma


subject: CHEMBL.COMPOUND:CHEMBL1743075

subject_name: TABALUMAB


subject: UMLS:C2984518


subject: CHEBI:44915

subject_name: Propofol

object_name: Emergence Delirium


subject: CHEBI:44915

object_name: post-operative delirium


subject: CHEBI:9130

subject_name: Sevoflurane


subject: CHEBI:9130


subject: UNII:U6CKL88C8H

subject_name: GOCATAMIG

object_name: Small cell lung cancer extensive stage


subject: UMLS:C5446875

subject_name: Gocatamig


subject: UMLS:C5237476

subject_name: Rescue Medications


subject: CHEBI:8802

subject_name: Remifentanil

object_name: preeclampsia


subject: CHEBI:8802

object_name: preeclampsia/eclampsia 1


subject: CHEBI:8802

object_name: hypertension, pregnancy-induced


subject: CHEBI:8802

object_name: HELLP syndrome


subject: CHEBI:8802

object_name: pregnancy disorder


subject: UMLS:C3892043

subject_name: Ibuprofen Injection

object_name: obesity due to melanocortin 4 receptor deficiency


subject: UMLS:C3892043

object_name: obesity


subject: UMLS:C3892043

object_name: Obesity, CTCAE


subject: UMLS:C3492748

object_name: beta thalassemia


subject: UMLS:C3492748

object_name: beta-thalassemia HBB/LCRB


subject: CHEBI:46987

subject_name: L-ARABINOSE

object_name: Prediabetes


subject: CHEBI:30849

subject_name: L-arabinose


subject: UMLS:C2348261

subject_name: Dietary Chromium


subject: CHEBI:28073

subject_name: Chromium


subject: CHEBI:49544

subject_name: Chromic cation


subject: CHEBI:89324

subject_name: 24,25-Dihydroxyvitamin D

object_name: magnesium deficiency


subject: CHEBI:89324

object_name: Overweight and obesity


subject: CHEBI:89324

object_name: Heart Disease Risk Factors


subject: UMLS:C3714503

subject_name: Vitamin D Drug Class


subject: UMLS:C3714503


subject: UMLS:C3714503


subject: UNII:9VU1KI44GP

subject_name: VITAMIN D


subject: UNII:9VU1KI44GP


subject: UNII:9VU1KI44GP


subject: UMLS:C2936842

subject_name: Vitamin D [EPC]


subject: UMLS:C2936842


subject: UMLS:C2936842


subject: CHEBI:27300

subject_name: Ergocalciferol


subject: CHEBI:27300


subject: CHEBI:27300


subject: UMLS:C3537249

subject_name: D Vitamin


subject: UMLS:C3537249


subject: UMLS:C3537249


subject: UMLS:C3540792

subject_name: Magnesium supplements, alimentary tract and metabolism

object_name: vitamin D deficiency


subject: UMLS:C3540792


subject: UMLS:C3540792


subject: UMLS:C3540792


subject: CHEBI:25107

subject_name: magnesium atom


subject: CHEBI:25107


subject: CHEBI:25107


subject: CHEBI:25107


subject: CHEBI:18420


subject: CHEBI:18420


subject: CHEBI:18420


subject: CHEBI:18420


subject: UMLS:C3714621

subject_name: Magnesium Drug Class


subject: UMLS:C3714621


subject: UMLS:C3714621


subject: UMLS:C3714621


subject: CHEBI:63607

subject_name: Linezolid

object_name: Skin and Connective Tissue Diseases


subject: CHEBI:63607

object_name: gram-positive bacterial infections


subject: UNII:2M2GGL7HUP

subject_name: FOLLITROPIN DELTA

object_name: infertility


subject: UMLS:C4301617

subject_name: follitropin delta


subject: UNII:4EQZ6YO2HI

subject_name: Denosumab

object_name: kidney failure


subject: UMLS:C1530450

subject_name: AMG 162


subject: CHEBI:49325

subject_name: oral contraceptive

object_name: Androgen excess


subject: UMLS:C0009905

subject_name: Contraceptives, Oral


subject: CHEBI:9241

subject_name: Spironolactone


subject: PUBCHEM.COMPOUND:23144079

subject_name: Milataxel

object_name: Mesothelioma


subject: PUBCHEM.COMPOUND:23144079

object_name: mesothelial neoplasm


subject: PUBCHEM.COMPOUND:23144079

object_name: malignant mesothelioma


subject: CHEBI:18167

subject_name: alpha-maltose

object_name: obesity due to melanocortin 4 receptor deficiency


subject: CHEBI:18167

object_name: obesity


subject: CHEBI:18167

object_name: Obesity, CTCAE


subject: CHEMBL.COMPOUND:CHEMBL2107951

subject_name: MALTODEXTRIN


subject: CHEMBL.COMPOUND:CHEMBL2107951


subject: CHEMBL.COMPOUND:CHEMBL2107951


subject: UMLS:C2370269

subject_name: stevia extract


subject: UMLS:C2370269


subject: UMLS:C2370269


subject: CHEBI:145012

subject_name: Rebaudioside A


subject: CHEBI:145012


subject: CHEBI:145012


subject: HMDB:HMDB0001960

subject_name: Tin

object_name: Thromboembolism


subject: CHEBI:30476


subject: UMLS:C0591649

subject_name: Innohep


subject: CHEMBL.COMPOUND:CHEMBL3833386

subject_name: GALINPEPIMUT-S

object_name: malignant pleural mesothelioma


subject: UMLS:C5206092

subject_name: Galinpepimut-S


subject: MESH:C000712049

subject_name: Monatide (IMS 3015)


subject: GTOPDB:4942

subject_name: GM-CSF


subject: UNII:5TAA004E22

subject_name: Sargramostim


subject: PR:000005931


subject: UMLS:C0376563

subject_name: Recombinant Granulocyte-Macrophage Colony-Stimulating Factors


subject: CHEBI:2948

subject_name: Azathioprine

object_name: inflammatory bowel disease 1


subject: CHEBI:2948

object_name: Crohn disease


subject: UNII:CUJ2MVI71Y

subject_name: Daclizumab

object_name: end stage renal failure


subject: UMLS:C0281549

subject_name: Zenapax


subject: UMLS:C0359156

subject_name: Thymoglobulin


subject: UMLS:C0594372

subject_name: Avonex

object_name: relapsing-remitting multiple sclerosis


subject: UMLS:C4053589

subject_name: Wnt Signaling Inhibitor SM04755

object_name: liver cancer


subject: UMLS:C4053589

object_name: Stomach cancer


subject: UMLS:C4053589

object_name: gastric cancer


subject: UMLS:C4053589

object_name: pancreatic neoplasm


subject: UMLS:C4053589

object_name: exocrine pancreatic carcinoma


subject: UMLS:C4053589

object_name: malignant pancreatic neoplasm


subject: UMLS:C4053589

object_name: colorectal cancer


subject: UMLS:C4053589

object_name: colorectal carcinoma


subject: UMLS:C4053589

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: UMLS:C4053589

object_name: liver carcinoma


subject: GTOPDB:9758

subject_name: camrelizumab

object_name: HER2-positive gastric cancer


subject: UNII:73096E137E


subject: UMLS:C4085979


subject: UNII:CJN36EQM0H

subject_name: Pyrotinib


subject: MESH:C520255

subject_name: 130-nm albumin-bound paclitaxel


subject: CHEBI:32188

subject_name: Tegafur


subject: CHEBI:83766

subject_name: Olaparib

object_name: triple-negative breast carcinoma


subject: CHEBI:83766

object_name: Triple-Negative Breast Cancer Finding


subject: UMLS:C0919079

subject_name: TEMOZOLOMIDE, ORAL, 5 MG ADMINISTERED


subject: UMLS:C0919079


subject: CHEBI:72564

subject_name: Temozolomide


subject: CHEBI:72564


subject: CHEBI:499361

subject_name: Aprepitant

object_name: aquagenic pruritus


subject: CHEBI:499361

object_name: bone marrow neoplasm


subject: UMLS:C3713949

object_name: Crohn disease


subject: UMLS:C4309188

object_name: Hypercholesterolemia


subject: PUBCHEM.COMPOUND:25136944

subject_name: Navelbine

object_name: non-small cell lung carcinoma


subject: CHEBI:2567

subject_name: Alendronic acid

object_name: chronic kidney disease


subject: CHEBI:2567

object_name: Chronic uremia


subject: CHEBI:135983

subject_name: Teriparatide


subject: CHEBI:135983


subject: CHEMBL.COMPOUND:CHEMBL3545411

object_name: Hot Flashes, CTCAE


subject: CHEMBL.COMPOUND:CHEMBL3545411

object_name: Hot flashes


subject: UMLS:C4305793


subject: UMLS:C4305793


subject: CHEBI:50275

subject_name: Esomeprazole

object_name: Chest pain


subject: CHEBI:77260

subject_name: Omeprazole


subject: MESH:C520255

object_name: Carcinoma breast stage IV


subject: UNII:CWG62Q1VTB

subject_name: Sitravatinib


subject: GTOPDB:9592

subject_name: tislelizumab


subject: CHEMBL.COMPOUND:CHEMBL4297840

subject_name: TISLELIZUMAB


subject: UMLS:C4053664


subject: CHEBI:49900

subject_name: Arsenous acid

object_name: Adult Myelodysplastic Syndrome


subject: CHEBI:49900

object_name: childhood myelodysplastic syndrome


subject: CHEBI:49900

object_name: Myelodysplastic Syndrome, CTCAE


subject: PUBCHEM.COMPOUND:518740

subject_name: Arsenic trioxide


subject: PUBCHEM.COMPOUND:518740


subject: PUBCHEM.COMPOUND:518740


subject: CHEBI:30621

subject_name: diarsenic trioxide


subject: CHEBI:30621


subject: CHEBI:30621


subject: UNII:S7V92P67HO


subject: UNII:S7V92P67HO


subject: UNII:S7V92P67HO


subject: UMLS:C0359949

subject_name: epinephrine / lidocaine

object_name: Surgical procedure finding


subject: UMLS:C0359949

object_name: Fractured forearm bone


subject: UMLS:C5783284

subject_name: ROPivacaine 0.75% injectable solution


subject: UMLS:C5783284


subject: UMLS:C1667763

object_name: respiratory syncytial virus infectious disease


subject: CHEBI:7773

subject_name: Ondansetron

object_name: diabetes mellitus


subject: CHEBI:7773

object_name: dyspepsia


subject: UNII:5TAA004E22

subject_name: Sargramostim

object_name: Alzheimer disease


subject: GTOPDB:5962

subject_name: dovitinib

object_name: bladder tumor


subject: GTOPDB:5962

object_name: urinary bladder carcinoma


subject: GTOPDB:5962

object_name: urinary bladder cancer


subject: GTOPDB:5962

object_name: childhood bladder carcinoma


subject: CHEBI:184910

subject_name: Rotigotine

object_name: fibromyalgia


subject: CHEBI:49575

subject_name: Diazepam

object_name: alcohol withdrawal delirium


subject: UMLS:C3540798

subject_name: Food allergenic extracts

object_name: obesity due to melanocortin 4 receptor deficiency


subject: UMLS:C3540798

object_name: obesity


subject: UMLS:C3540798

object_name: Obesity, CTCAE


subject: CHEBI:41879

subject_name: Dexamethasone

object_name: Premature birth


subject: UNII:37CQ2C7X93

subject_name: Canakinumab

object_name: pyoderma gangrenosum


subject: UMLS:C2718754

subject_name: Ilaris


subject: CHEBI:41879

object_name: benign prostatic hyperplasia


subject: CHEBI:8988

object_name: gastric neoplasm


subject: CHEBI:80630

subject_name: Irinotecan


subject: CHEBI:139072

object_name: Depressed mood


subject: CHEBI:139072

object_name: Cancer patients and suicide and depression


subject: CHEBI:139072

object_name: Depressed - symptom


subject: CHEBI:139072

object_name: Depression, CTCAE


subject: CHEBI:139072

object_name: Parkinson disease


subject: CHEBI:8614

subject_name: Psilocybin


subject: CHEBI:8614


subject: CHEBI:8614


subject: CHEBI:8614


subject: CHEBI:8614


subject: CHEBI:71954

subject_name: Buparlisib

object_name: metastatic colorectal cancer


subject: UNII:6A901E312A

subject_name: Panitumumab


subject: CHEBI:7772

subject_name: omeprazole

object_name: gastric ulcer


subject: CHEBI:7772

object_name: Stomach Ulcer, CTCAE


subject: UMLS:C0591742

subject_name: Losec

object_name: Heartburn


subject: UMLS:C0591742


subject: UMLS:C0591742


subject: CHEBI:77260

subject_name: Omeprazole


subject: CHEBI:77260


subject: GTOPDB:12101

subject_name: zigakibart

object_name: immunoglobulin disease


subject: GTOPDB:12101

object_name: Glomerulopathy


subject: GTOPDB:12101

object_name: IgA Nephropathy


subject: GTOPDB:12101

object_name: IgA nephropathy, susceptibility to, 1


subject: GTOPDB:12101

object_name: glomerulonephritis


subject: GTOPDB:12101

object_name: chronic kidney disease


subject: GTOPDB:12101

object_name: urinary system disorder


subject: GTOPDB:12101

object_name: Glomerular vascular disorder


subject: GTOPDB:12101

object_name: kidney disorder


subject: CHEMBL.COMPOUND:CHEMBL5095316

subject_name: ZIGAKIBART


subject: CHEMBL.COMPOUND:CHEMBL5095316


subject: CHEMBL.COMPOUND:CHEMBL5095316


subject: CHEMBL.COMPOUND:CHEMBL5095316


subject: CHEMBL.COMPOUND:CHEMBL5095316


subject: CHEMBL.COMPOUND:CHEMBL5095316


subject: CHEMBL.COMPOUND:CHEMBL5095316


subject: CHEMBL.COMPOUND:CHEMBL5095316


subject: CHEMBL.COMPOUND:CHEMBL5095316


subject: UMLS:C4684843

subject_name: Zigakibart


subject: UMLS:C4684843


subject: UMLS:C4684843


subject: UMLS:C4684843


subject: UMLS:C4684843


subject: UMLS:C4684843


subject: UMLS:C4684843


subject: UMLS:C4684843


subject: UMLS:C4684843


subject: CHEBI:209807

subject_name: Cefoxitin

object_name: appendicitis


subject: CHEBI:81579

subject_name: Erythropoietin

object_name: precancerous condition


subject: CHEBI:81579

object_name: unspecified adult solid tumor, protocol specific


subject: CHEBI:81579

object_name: lymphoproliferative syndrome


subject: CHEBI:81579

object_name: leukemia


subject: CHEBI:81579

object_name: childhood leukemia


subject: CHEBI:81579

object_name: adult lymphoma


subject: CHEBI:81579

object_name: lymphoma


subject: CHEBI:81579

object_name: pediatric lymphoma


subject: PUBCHEM.COMPOUND:92043599

subject_name: epoetin alfa


subject: PUBCHEM.COMPOUND:92043599


subject: PUBCHEM.COMPOUND:92043599


subject: PUBCHEM.COMPOUND:92043599


subject: PUBCHEM.COMPOUND:92043599


subject: PUBCHEM.COMPOUND:92043599


subject: PUBCHEM.COMPOUND:92043599


subject: PUBCHEM.COMPOUND:92043599


subject: CHEBI:134736

subject_name: Vintafolide

object_name: Solid Neoplasm


subject: UMLS:C2984015

object_name: neoplasm


subject: UMLS:C5783941

subject_name: P2Y12 Inhibitor

object_name: coronary artery disorder


subject: UMLS:C5783941

object_name: coronary atherosclerosis


subject: CHEBI:5001

subject_name: Fenofibrate

object_name: arteriosclerosis disorder


subject: CHEBI:5001

object_name: atherosclerosis


subject: CHEBI:5001

object_name: type 2 diabetes mellitus


subject: CHEBI:25681

subject_name: Omega-3 fatty acids

object_name: language disorder


subject: CHEBI:25681

object_name: specific language impairment 5


subject: UNII:52CMI0WC3Y

subject_name: Atezolizumab


subject: UNII:52CMI0WC3Y

object_name: Stage IV Rectal Cancer AJCC v8


subject: UNII:52CMI0WC3Y

object_name: Stage IVB Rectal Cancer AJCC v8


subject: UNII:52CMI0WC3Y

object_name: Stage IVA Rectal Cancer AJCC v8


subject: UNII:52CMI0WC3Y

object_name: Metastatic Malignant Solid Neoplasm


subject: UNII:52CMI0WC3Y

object_name: Stage IV Colon Cancer AJCC v8


subject: UNII:52CMI0WC3Y

object_name: Stage IVB Colon Cancer AJCC v8


subject: UNII:52CMI0WC3Y

object_name: Stage IVA Colon Cancer AJCC v8


subject: UNII:52CMI0WC3Y

object_name: rectum adenocarcinoma


subject: UNII:52CMI0WC3Y

object_name: colon adenocarcinoma


subject: UMLS:C3827082


subject: UMLS:C3827082


subject: UMLS:C3827082


subject: UMLS:C3827082


subject: UMLS:C3827082


subject: UMLS:C3827082


subject: UMLS:C3827082


subject: UMLS:C3827082


subject: UMLS:C3827082


subject: UMLS:C3827082


subject: UNII:M89N0Q7EQR

subject_name: Aldesleukin

object_name: renal carcinoma


subject: UNII:M89N0Q7EQR

object_name: kidney neoplasm


subject: UNII:M89N0Q7EQR

object_name: kidney cancer


subject: PR:000001379


subject: PR:000001379


subject: PR:000001379


subject: CHEBI:41879

subject_name: Dexamethasone

object_name: bronchiolitis


subject: CHEBI:7772

object_name: Peripheral neuropathy due to and following antineoplastic therapy


subject: CHEBI:77260


subject: CHEBI:8426

subject_name: Probenecid

object_name: heart failure


subject: CHEBI:8426

object_name: Heart Failure, CTCAE


subject: DRUGBANK:DB17970

object_name: Thymidine kinase 2 deficiency


subject: DRUGBANK:DB17970

object_name: mitochondrial DNA depletion syndrome, myopathic form


subject: UMLS:C1527127

object_name: adult lymphoma


subject: UMLS:C1527127

object_name: lymphoma


subject: UMLS:C1527127

object_name: pediatric lymphoma


subject: CHEBI:135945

subject_name: Pixantrone


subject: CHEBI:135945


subject: CHEBI:135945


subject: CHEBI:114785

subject_name: Erlotinib

object_name: unspecified adult solid tumor, protocol specific


subject: UMLS:C0964609

object_name: xerophthalmia


subject: UMLS:C0964609

object_name: dry eye syndrome


subject: UMLS:C0964609

object_name: Dry Eye Syndrome, CTCAE


subject: CHEBI:6801

subject_name: Metformin

object_name: morbid obesity


subject: CHEBI:6801

object_name: Class 3 Obesity


subject: DRUGBANK:DB11357

subject_name: Linseed oil

object_name: Overweight


subject: DRUGBANK:DB11357

object_name: Hypercholesterolemia


subject: PUBCHEM.COMPOUND:152165

object_name: Prolapsed thoracic intervertebral disc


subject: CHEBI:47381

subject_name: Diclofenac


subject: PUBCHEM.COMPOUND:135565610

subject_name: hetrombopag

object_name: pulmonary fibrosis and/or bone marrow failure, Telomere-related, 2


subject: PUBCHEM.COMPOUND:135565610

object_name: aplastic anemia


subject: PUBCHEM.COMPOUND:135565610

object_name: idiopathic aplastic anemia


subject: PUBCHEM.COMPOUND:135565610

object_name: autoimmune thrombocytopenic purpura


subject: UNII:9WGT51BDDL

subject_name: Hetrombopag


subject: UNII:9WGT51BDDL


subject: UNII:9WGT51BDDL


subject: UNII:9WGT51BDDL


subject: UMLS:C5785765

object_name: metastatic malignant neoplasm in the brain


subject: UMLS:C5785765

object_name: Triple-Negative Breast Cancer Finding


subject: UNII:2S9ZZM9Q9V

subject_name: Bevacizumab


subject: CHEBI:3395

subject_name: carbidopa

object_name: Parkinson disease


subject: CHEBI:94430

subject_name: DL-Carbidopa


subject: CHEBI:39585

subject_name: Carbidopa


subject: UMLS:C5433201

subject_name: Daptomycin for Injection

object_name: Soft Tissue Infection


subject: UMLS:C5433201

object_name: bacteriemia


subject: UMLS:C5433201

object_name: Bacteremia, CTCAE


subject: UMLS:C5433201

object_name: skin disorder caused by infection


subject: UMLS:C5433201

object_name: skin infection


subject: UMLS:C0718276

subject_name: Adult Strength

object_name: HIV-1 infection


subject: UNII:4Z63YK6E0E

subject_name: Daratumumab

object_name: autoimmune thrombocytopenia


subject: UNII:4Z63YK6E0E

object_name: thrombocytopenia due to immune destruction


subject: UNII:4Z63YK6E0E


subject: UMLS:C0935699

object_name: Childhood Breast Carcinoma


subject: UMLS:C0935699

object_name: breast carcinoma


subject: UMLS:C0935699

object_name: breast cancer


subject: CHEBI:5441

subject_name: Glyburide

object_name: Diabetes


subject: CHEBI:5441

object_name: diabetes mellitus


subject: CHEBI:71272

subject_name: Saxagliptin


subject: CHEBI:71272


subject: CHEBI:135905

subject_name: Terlipressin

object_name: Renal function disorder


subject: CHEBI:291342

subject_name: Desloratadine

object_name: acquired cold urticaria


subject: UNII:40SGR63TGL

subject_name: Minodronic acid

object_name: osteoporosis


subject: UMLS:C4018781

subject_name: human milk preparation

object_name: Well adult


subject: UMLS:C4018781

object_name: Effects of high altitude


subject: UMLS:C0962969

subject_name: RAD 001

object_name: plexiform neurofibroma


subject: UMLS:C0962969

object_name: neurofibromatosis 1


subject: UMLS:C0962969

object_name: neurofibromatosis type 1


subject: UMLS:C0962969

object_name: neurofibroma


subject: PUBCHEM.COMPOUND:70789204

subject_name: Everolimus


subject: PUBCHEM.COMPOUND:70789204


subject: PUBCHEM.COMPOUND:70789204


subject: PUBCHEM.COMPOUND:70789204


subject: UNII:R67KC9COEN

object_name: asthma


subject: CHEMBL.COMPOUND:CHEMBL3707249


subject: CHEBI:41879

subject_name: Dexamethasone

object_name: type 2 diabetes mellitus


subject: CHEBI:9150

subject_name: Simvastatin

object_name: kidney failure


subject: CHEBI:77562

subject_name: rac-crizotinib

object_name: ALK-positive anaplastic large cell lymphoma


subject: CHEBI:64310

subject_name: Crizotinib


subject: CHEBI:94782

subject_name: Cediranib

object_name: Solid Neoplasm


subject: UMLS:C2986405

subject_name: PankoMab-GEX


subject: CHEBI:94534

subject_name: olanzapine


subject: CHEBI:94534


subject: CHEBI:94534


subject: CHEBI:94534

object_name: Insulin resistance


subject: CHEBI:9907

subject_name: ursodiol

object_name: Neonatal hyperbilirubinemia


subject: CHEBI:35176

subject_name: Zinc sulfate


subject: CHEMBL.COMPOUND:CHEMBL2109625

object_name: West Nile fever


subject: CHEBI:132967

subject_name: Elbasvir

object_name: Medication interaction potentiation


subject: UNII:4O2AB118LA

subject_name: GRAZOPREVIR


subject: CHEBI:132975

subject_name: Grazoprevir


subject: CHEMBL.COMPOUND:CHEMBL2109673

subject_name: PTI-6D2 188RE

object_name: metastatic melanoma


subject: CHEBI:6532

subject_name: Loperamide

object_name: Bowel incontinence


subject: CHEBI:6532

object_name: Fecal Incontinence, CTCAE


subject: CHEMBL.COMPOUND:CHEMBL2108693

subject_name: SYRUP


subject: CHEMBL.COMPOUND:CHEMBL2108693


subject: MESH:D013607

subject_name: Tablets


subject: MESH:D013607


subject: CHEBI:132082

subject_name: Entinostat

object_name: invasive breast carcinoma


subject: CHEBI:132082

object_name: Anatomic Stage IV Breast Cancer AJCC v8


subject: CHEBI:132082

object_name: Anatomic Stage III Breast Cancer AJCC v8


subject: CHEBI:132082

object_name: breast adenocarcinoma


subject: CHEBI:132082

object_name: Malignant Solid Neoplasm


subject: CHEBI:231679

subject_name: ipilimumab


subject: CHEBI:231679


subject: CHEBI:231679


subject: CHEBI:231679


subject: CHEBI:231614

subject_name: Nivolumab


subject: CHEBI:231614


subject: CHEBI:231614


subject: CHEBI:231614


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: CHEBI:39548

subject_name: Atorvastatin

object_name: epilepsy


subject: CHEBI:8107

subject_name: Phenytoin


subject: CHEBI:94531

subject_name: belinostat

object_name: Non-Hodgkin's lymphoma refractory


subject: CHEBI:94531

object_name: T-cell lymphoma refractory


subject: CHEBI:94531

object_name: Follicular lymphoma refractory


subject: CHEBI:94531

object_name: Refractory Transformed Non-Hodgkin Lymphoma


subject: CHEBI:94531

object_name: B-cell lymphoma refractory


subject: CHEBI:94531

object_name: Refractory Primary Cutaneous T-Cell Non-Hodgkin Lymphoma


subject: CHEBI:94531

object_name: Non-Hodgkin's lymphoma transformed recurrent


subject: CHEBI:94531

object_name: Refractory Diffuse Large B-Cell Lymphoma Germinal Center B-Cell Type


subject: CHEBI:94531

object_name: Recurrent Adult Non-Hodgkin Lymphoma


subject: CHEBI:94531

object_name: Recurrent Childhood Non-Hodgkin Lymphoma


subject: CHEBI:94531

object_name: Recurrent Non-Hodgkin Lymphoma


subject: CHEBI:94531

object_name: Follicular lymphoma recurrent


subject: CHEBI:94531

object_name: T-cell lymphoma recurrent


subject: CHEBI:94531

object_name: B-cell lymphoma recurrent


subject: CHEBI:94531

object_name: Recurrent Diffuse Large B-Cell Lymphoma Germinal Center B-Cell Type


subject: CHEBI:94531

object_name: Recurrent Primary Cutaneous T-Cell Non-Hodgkin Lymphoma


subject: CHEBI:231598

subject_name: Tazemetostat


subject: CHEBI:231598


subject: CHEBI:231598


subject: CHEBI:231598


subject: CHEBI:231598


subject: CHEBI:231598


subject: CHEBI:231598


subject: CHEBI:231598


subject: CHEBI:231598


subject: CHEBI:231598


subject: CHEBI:231598


subject: CHEBI:231598


subject: CHEBI:231598


subject: CHEBI:231598


subject: CHEBI:3732

subject_name: Clarithromycin

object_name: Plasma cell myeloma refractory


subject: CHEBI:3732

object_name: Relapse multiple myeloma


subject: CHEBI:72690

subject_name: Pomalidomide


subject: CHEBI:36796

subject_name: duloxetine

object_name: Dysesthesia


subject: UNII:5T4TX6CO53


subject: UMLS:C1958615


subject: CHEBI:601027

subject_name: Aliskiren

object_name: essential hypertension


subject: UMLS:C0022478

subject_name: kininogenase

object_name: stroke disorder


subject: UMLS:C0022478

object_name: cerebral infarction


subject: UMLS:C0022478

object_name: cerebrovascular disorder


subject: UMLS:C5551415

subject_name: Kallikrein


subject: UMLS:C5551415


subject: UMLS:C5551415


subject: UMLS:C3540708

subject_name: Antibiotics, Gynecological

object_name: Infection


subject: UMLS:C3540708

object_name: Infection of musculoskeletal system


subject: UMLS:C3540708

object_name: IgG Deficiency


subject: UMLS:C3540708

object_name: selective IgG immunodeficiency


subject: UMLS:C3540708

object_name: Decreased circulating IgG concentration


subject: MESH:D000904

subject_name: Antibiotics, Antitubercular


subject: MESH:D000904


subject: MESH:D000904


subject: MESH:D000904


subject: MESH:D000904


subject: UMLS:C3540709

subject_name: antibiotics, intestinal


subject: UMLS:C3540709


subject: UMLS:C3540709


subject: UMLS:C3540709


subject: UMLS:C3540709


subject: UMLS:C3540707

subject_name: Antibiotics FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE


subject: UMLS:C3540707


subject: UMLS:C3540707


subject: UMLS:C3540707


subject: UMLS:C3540707


subject: UMLS:C0003232

subject_name: Antibiotics


subject: UMLS:C0003232


subject: UMLS:C0003232


subject: UMLS:C0003232


subject: UMLS:C3540704

subject_name: Antibiotics for systemic use


subject: UMLS:C3540704


subject: UMLS:C3540704


subject: UMLS:C3540704


subject: UMLS:C3540704


subject: UMLS:C3540706

subject_name: Antibiotic throat preparations


subject: UMLS:C3540706


subject: UMLS:C3540706


subject: UMLS:C3540706


subject: UMLS:C3540706


subject: UMLS:C3540710

subject_name: Antibiotics, ophthalmologic


subject: UMLS:C3540710


subject: UMLS:C3540710


subject: UMLS:C3540710


subject: UMLS:C3540710


subject: UMLS:C3540705

subject_name: Antifungal Antibiotics, Topical


subject: UMLS:C3540705


subject: UMLS:C3540705


subject: UMLS:C3540705


subject: UMLS:C3540705


subject: UMLS:C0085297

subject_name: immunoglobulins, intravenous


subject: UMLS:C0085297


subject: UMLS:C0085297


subject: UMLS:C0085297


subject: UMLS:C0085297


subject: PUBCHEM.COMPOUND:11531537

subject_name: Eliglustat

object_name: Gaucher disease type III


subject: PUBCHEM.COMPOUND:9848990

subject_name: BUPRENORPHINE

object_name: heroin dependence


subject: CHEBI:7459

subject_name: Naloxone


subject: CHEBI:77562

subject_name: rac-crizotinib

object_name: inflammatory myofibroblastic tumor


subject: CHEBI:77562

object_name: anaplastic large cell lymphoma


subject: CHEBI:64310

subject_name: Crizotinib


subject: CHEBI:64310


subject: CHEBI:15367

subject_name: Tretinoin

object_name: Solar elastosis


subject: CHEBI:50648

subject_name: Alitretinoin


subject: GTOPDB:13769

subject_name: retatrutide

object_name: Overweight


subject: GTOPDB:13769

object_name: obesity due to melanocortin 4 receptor deficiency


subject: GTOPDB:13769

object_name: obesity


subject: GTOPDB:13769

object_name: Obesity, CTCAE


subject: CHEMBL.COMPOUND:CHEMBL5095485

subject_name: RETATRUTIDE


subject: CHEMBL.COMPOUND:CHEMBL5095485


subject: CHEMBL.COMPOUND:CHEMBL5095485


subject: CHEMBL.COMPOUND:CHEMBL5095485


subject: UniProtKB:P05879

subject_name: ENV_HV1C4 Envelope glycoprotein gp160 (sprot)

object_name: HIV infection


subject: UniProtKB:P20829

subject_name: ENV2_DROME Retrovirus-related Env polyprotein from transposon 297 (sprot)


subject: UniProtKB:P16082

subject_name: ENV_EIAVW Envelope glycoprotein (sprot)


subject: UniProtKB:P10403

subject_name: ENV1_DROME Retrovirus-related Env polyprotein from transposon gypsy (sprot)


subject: UniProtKB:P03383

subject_name: ENV_HTLV2 Envelope glycoprotein gp63 (sprot)


subject: UniProtKB:P20871

subject_name: ENV_HV1JR Envelope glycoprotein gp160 (sprot)


subject: UniProtKB:P11370

subject_name: ENV2_MOUSE Retrovirus-related Env polyprotein from Fv-4 locus (sprot)


subject: PR:000003225

subject_name: HIV env gene translation product


subject: UniProtKB:P04283

subject_name: ENV17_DROME Retrovirus-related Env polyprotein from copia-like transposable element 17.6 (sprot)


subject: UniProtKB:P03378

subject_name: ENV_HV1A2 Envelope glycoprotein gp160 (sprot)


subject: PR:000007741

subject_name: retrovirus-related Env polyprotein from Fv-4 locus


subject: UMLS:C0003323

subject_name: CD4 Antigens


subject: CHEBI:4672

subject_name: Docetaxel

object_name: carcinoma


subject: CHEBI:4672

object_name: nasopharyngeal neoplasm


subject: CHEBI:31355

subject_name: Carboplatin

object_name: pleural mesothelioma


subject: CHEBI:31355

object_name: malignant pleural mesothelioma


subject: CHEBI:150712

subject_name: Hyaluronic acid

object_name: Arthralgia


subject: CHEBI:150712

object_name: Arthralgia, CTCAE


subject: CHEBI:150712

object_name: Breast neoplasm female


subject: CHEMBL.COMPOUND:CHEMBL5314376

subject_name: HYALURONIC ACID


subject: CHEMBL.COMPOUND:CHEMBL5314376


subject: CHEMBL.COMPOUND:CHEMBL5314376


subject: CHEBI:33349

subject_name: dubnium atom


subject: CHEBI:33349


subject: CHEBI:33349


subject: CHEBI:33357

subject_name: hassium atom


subject: CHEBI:33357


subject: CHEBI:33357


subject: CHEBI:133630

subject_name: His-Ala


subject: CHEBI:133630


subject: CHEBI:133630


subject: UniProtKB:P03456

subject_name: HEMA_I68A3 Hemagglutinin (sprot)


subject: UniProtKB:P03456


subject: UniProtKB:P03456


subject: UniProtKB:P03446

subject_name: HEMA_I76A2 Hemagglutinin (sprot)


subject: UniProtKB:P03446


subject: UniProtKB:P03446


subject: UniProtKB:A3DRP0

subject_name: HEMA_I96A2 Hemagglutinin (sprot)


subject: UniProtKB:A3DRP0


subject: UniProtKB:A3DRP0


subject: UniProtKB:A4K143

subject_name: HEMA_I54A2 Hemagglutinin (sprot)


subject: UniProtKB:A4K143


subject: UniProtKB:A4K143


subject: UniProtKB:B4URD6

subject_name: HEMA_I06A0 Hemagglutinin (sprot)


subject: UniProtKB:B4URD6


subject: UniProtKB:B4URD6


subject: UniProtKB:Q0A448

subject_name: hemagglutinin (Influenza A virus (strain A/Duck/Germany/1949 H10N7))


subject: UniProtKB:Q0A448


subject: UniProtKB:Q0A448


subject: UMLS:C4285347

subject_name: Ha Antibody


subject: UMLS:C4285347


subject: UMLS:C4285347


subject: UniProtKB:Q9WCD8

subject_name: HEMA_I61A1 Hemagglutinin (sprot)


subject: UniProtKB:Q9WCD8


subject: UniProtKB:Q9WCD8


subject: UniProtKB:P03453

subject_name: HEMA_I77AB Hemagglutinin (sprot)


subject: UniProtKB:P03453


subject: UniProtKB:P03453


subject: UniProtKB:A4U7A6

subject_name: HEMA_I51A0 Hemagglutinin (sprot)


subject: UniProtKB:A4U7A6


subject: UniProtKB:A4U7A6


subject: UniProtKB:P13103

subject_name: HEMA_I77AF Hemagglutinin (sprot)


subject: UniProtKB:P13103


subject: UniProtKB:P13103


subject: UniProtKB:P26136

subject_name: HEMA_I82A1 Hemagglutinin (sprot)


subject: UniProtKB:P26136


subject: UniProtKB:P26136


subject: UniProtKB:P07976

subject_name: HEMA_I83A5 Hemagglutinin (sprot)


subject: UniProtKB:P07976


subject: UniProtKB:P07976


subject: UniProtKB:A4GBX7

subject_name: HEMA_I77AA Hemagglutinin (sprot)


subject: UniProtKB:A4GBX7


subject: UniProtKB:A4GBX7


subject: UniProtKB:P19698

subject_name: HEMA_I79A7 Hemagglutinin (sprot)


subject: UniProtKB:P19698


subject: UniProtKB:P19698


subject: UniProtKB:Q6LEJ4

subject_name: HEMA_I80A2 Hemagglutinin (sprot)


subject: UniProtKB:Q6LEJ4


subject: UniProtKB:Q6LEJ4


subject: UniProtKB:P03457

subject_name: HEMA_I66A1 Hemagglutinin (sprot)


subject: UniProtKB:P03457


subject: UniProtKB:P03457


subject: UniProtKB:A4GCL9

subject_name: HEMA_I35A3 Hemagglutinin (sprot)


subject: UniProtKB:A4GCL9


subject: UniProtKB:A4GCL9


subject: UniProtKB:Q9WFX3

subject_name: HEMA_I18A0 Hemagglutinin (sprot)


subject: UniProtKB:Q9WFX3


subject: UniProtKB:Q9WFX3


subject: UniProtKB:A4U6V2

subject_name: HEMA_I45A0 Hemagglutinin (sprot)


subject: UniProtKB:A4U6V2


subject: UniProtKB:A4U6V2


subject: UniProtKB:Q07FI5

subject_name: HEMA_I96A3 Hemagglutinin (sprot)


subject: UniProtKB:Q07FI5


subject: UniProtKB:Q07FI5


subject: UniProtKB:P03454

subject_name: HEMA_I33A0 Hemagglutinin (sprot)


subject: UniProtKB:P03454


subject: UniProtKB:P03454


subject: UniProtKB:A4GCK8

subject_name: HEMA_I43A0 Hemagglutinin (sprot)


subject: UniProtKB:A4GCK8


subject: UniProtKB:A4GCK8


subject: UniProtKB:P03448

subject_name: HEMA_I72A5 Hemagglutinin (sprot)


subject: UniProtKB:P03448


subject: UniProtKB:P03448


subject: UniProtKB:A4GCI6

subject_name: HEMA_I36A0 Hemagglutinin (sprot)


subject: UniProtKB:A4GCI6


subject: UniProtKB:A4GCI6


subject: UniProtKB:A4GCJ7

subject_name: HEMA_I80AA Hemagglutinin (sprot)


subject: UniProtKB:A4GCJ7


subject: UniProtKB:A4GCJ7


subject: UniProtKB:P04661

subject_name: HEMA_I56A2 Hemagglutinin (sprot)


subject: UniProtKB:P04661


subject: UniProtKB:P04661


subject: UniProtKB:Q0HD60

subject_name: HEMA_I40A0 Hemagglutinin (sprot)


subject: UniProtKB:Q0HD60


subject: UniProtKB:Q0HD60


subject: UniProtKB:P26139

subject_name: HEMA_I77A4 Hemagglutinin (sprot)


subject: UniProtKB:P26139


subject: UniProtKB:P26139


subject: UniProtKB:A4GCH5

subject_name: HEMA_I83A1 Hemagglutinin (sprot)


subject: UniProtKB:A4GCH5


subject: UniProtKB:A4GCH5


subject: UMLS:C1527137

subject_name: Recombinant melatonin

object_name: essential hypertension


subject: CHEBI:16796

subject_name: Melatonin


subject: CHEBI:88464

subject_name: (9E,11E)-octadecadienoic acid

object_name: asthma


subject: CHEBI:36025

subject_name: octadeca-9,11-dienoic acid


subject: CHEBI:61159

subject_name: conjugated linoleic acid


subject: MESH:D044243

subject_name: Linoleic Acids, Conjugated


subject: CHEBI:41791

subject_name: calyculin A


subject: CHEBI:3732

subject_name: Clarithromycin


subject: CHEBI:24859

subject_name: iodine atom

object_name: Dental Plaque


subject: CHEBI:17606

subject_name: Iodine


subject: UMLS:C0885449

subject_name: Iodine, Homeopathic preparation


subject: PUBCHEM.COMPOUND:21879648

subject_name: Abiraterone

object_name: Stage IV Prostate Cancer AJCC v6


subject: PUBCHEM.COMPOUND:21879648

object_name: Carcinoma of the prostate stage IV


subject: PUBCHEM.COMPOUND:21879648

object_name: Stage IV Prostate Cancer AJCC v7


subject: PUBCHEM.COMPOUND:21879648

object_name: Advanced prostate cancer


subject: PUBCHEM.COMPOUND:21879648

object_name: prostate adenocarcinoma


subject: CHEBI:40799

subject_name: Boldione

object_name: prostate carcinoma


subject: CHEBI:40799

object_name: prostate cancer


subject: CHEBI:40799


subject: CHEBI:40799


subject: CHEBI:40799


subject: CHEBI:40799

object_name: Stage IV Prostate Cancer AJCC v8


subject: CHEBI:40799


subject: CHEBI:40799


subject: CHEBI:8382

subject_name: Prednisone


subject: CHEBI:194186

subject_name: Tirzepatide

object_name: Drug action (disorder)


subject: CHEBI:194186

object_name: Congenital musculoskeletal anomalies


subject: CHEBI:194186

object_name: Sarcopenic obesity


subject: CHEBI:194186

object_name: osteoporosis


subject: CHEBI:194186

object_name: Encounter due to family history of osteoporosis


subject: CHEBI:194186

object_name: Osteoporosis, CTCAE 5.0


subject: CHEBI:194186

object_name: Osteoporosis, CTCAE 3.0


subject: UNII:NS3988A2TC

subject_name: Selonsertib

object_name: diabetic kidney disease


subject: CHEBI:5931

subject_name: insulin human

object_name: Weight Gain


subject: CHEBI:5931

object_name: Weight Gain, CTCAE


subject: PUBCHEM.COMPOUND:11635624

subject_name: Edoxaban

object_name: heart valve disorder


subject: PUBCHEM.COMPOUND:11635624

object_name: Valvular Heart Disease, CTCAE


subject: PUBCHEM.COMPOUND:11635624

object_name: Atrial fibrillation and flutter


subject: CHEBI:16581

subject_name: Pregnenolone

object_name: bipolar disorder


subject: UNII:0T4IMT8S5Z

subject_name: Olutasidenib

object_name: Myelodysplasia


subject: UNII:0T4IMT8S5Z

object_name: Adult Myelodysplastic Syndrome


subject: UNII:0T4IMT8S5Z

object_name: childhood myelodysplastic syndrome


subject: UNII:0T4IMT8S5Z

object_name: Myelodysplastic Syndrome, CTCAE


subject: UNII:0T4IMT8S5Z

object_name: juvenile myelomonocytic leukemia


subject: UNII:0T4IMT8S5Z

object_name: chronic myelomonocytic leukemia


subject: UNII:0T4IMT8S5Z

object_name: acute myeloid leukemia by FAB classification


subject: UNII:0T4IMT8S5Z

object_name: acute myeloid leukemia


subject: CHEBI:191876

object_name: sleep apnea


subject: UMLS:C5556351

object_name: Advanced Malignant Solid Neoplasm


subject: UMLS:C5556351

object_name: pancreatic neoplasm


subject: UMLS:C5556351

object_name: exocrine pancreatic carcinoma


subject: UMLS:C5556351

object_name: malignant pancreatic neoplasm


subject: CHEBI:7496

subject_name: Nelfinavir

object_name: cervical intraepithelial neoplasia


subject: CHEBI:7496

object_name: dysplasia of cervix


subject: CHEBI:63632

subject_name: Topotecan

object_name: endometrial cancer


subject: CHEBI:63632

object_name: uterine corpus cancer


subject: CHEBI:63632

object_name: endometrial carcinoma


subject: GTOPDB:12989

subject_name: toripalimab


subject: GTOPDB:12989


subject: GTOPDB:12989


subject: UNII:8JXN261VVA


subject: UNII:8JXN261VVA


subject: UNII:8JXN261VVA


subject: UMLS:C4329337

subject_name: TAB 001


subject: UMLS:C4329337


subject: UMLS:C4329337


subject: UMLS:C4742113

object_name: cystic fibrosis


subject: CHEBI:63577

subject_name: Lamivudine

object_name: Hepatitis D, Chronic


subject: CHEBI:63577

object_name: polyarteritis nodosa


subject: CHEBI:63577

object_name: glomerulonephritis


subject: UNII:CJN36EQM0H

subject_name: Pyrotinib

object_name: Carcinoma breast stage IV


subject: UNII:16VY3TM7ZO

subject_name: Antineoplaston A10

object_name: Stage IV Bladder Cancer AJCC v8


subject: UNII:16VY3TM7ZO

object_name: Stage IV Bladder Cancer AJCC v7


subject: UNII:16VY3TM7ZO

object_name: Bladder cancer stage IV


subject: UNII:16VY3TM7ZO

object_name: Stage IV Bladder Cancer AJCC v6


subject: UMLS:C4721487

subject_name: ATENGENAL


subject: UMLS:C4721487


subject: UMLS:C4721487


subject: UMLS:C4721487


subject: UMLS:C4721495

subject_name: Astugenal


subject: UMLS:C4721495


subject: UMLS:C4721495


subject: UMLS:C4721495


subject: UMLS:C1541801

subject_name: TroVax

object_name: Childhood Breast Carcinoma


subject: UMLS:C1541801

object_name: breast carcinoma


subject: UMLS:C1541801

object_name: breast cancer


subject: UMLS:C4721782

subject_name: Pegargiminase

object_name: acute myeloid leukemia by FAB classification


subject: UMLS:C4721782

object_name: acute myeloid leukemia


subject: UMLS:C1328192

subject_name: ADI PEG20


subject: UMLS:C1328192


subject: CHEBI:41879

subject_name: Dexamethasone

object_name: keratoconus


subject: PUBCHEM.COMPOUND:49865963

subject_name: TRABECTEDIN

object_name: malignant soft tissue neoplasm


subject: PUBCHEM.COMPOUND:49865963

object_name: sarcoma


subject: PUBCHEM.COMPOUND:3199

subject_name: ecteinascidin 743


subject: PUBCHEM.COMPOUND:3199


subject: UMLS:C5708760

subject_name: Gallium Ga 68-NOTA-SNA002

object_name: Childhood Solid Neoplasm


subject: UMLS:C5708760

object_name: Adult Solid Neoplasm


subject: UMLS:C5708760

object_name: Solid Neoplasm


subject: CHEBI:87631

subject_name: statin

object_name: hyperlipidemia


subject: UMLS:C0007220

subject_name: Cardiovascular Agents


subject: UMLS:C5964839

object_name: Advanced cancer


subject: UMLS:C5964839

object_name: Disseminated Malignant Neoplasm


subject: UMLS:C5964839

object_name: Embolism, Tumor


subject: UMLS:C5964839

object_name: Neoplasm Metastasis


subject: UMLS:C5964839


subject: UMLS:C5964839


subject: UMLS:C5964839


subject: UNII:897NVD4A52

subject_name: p-Chloroamphetamine

object_name: pain agnosia


subject: UNII:897NVD4A52

object_name: Pain insensitivity


subject: CHEBI:62248


subject: CHEBI:62248


subject: CHEBI:36751


subject: CHEBI:36751


subject: CHEBI:16010


subject: CHEBI:16010


subject: UMLS:C0034330

subject_name: Pidolic acid


subject: UMLS:C0034330


subject: CHEBI:8382

subject_name: Prednisone

object_name: relapsing-remitting multiple sclerosis


subject: UNII:6A901E312A

subject_name: Panitumumab

object_name: pancreatic neoplasm


subject: UNII:6A901E312A

object_name: exocrine pancreatic carcinoma


subject: UNII:6A901E312A

object_name: malignant pancreatic neoplasm


subject: CHEBI:36080

subject_name: protein

object_name: sarcopenia


subject: UMLS:C0033684

subject_name: Proteins


subject: PR:000000001


subject: CHEBI:16646

subject_name: carbohydrate


subject: UMLS:C0019593

subject_name: Histamine H2 Antagonists

object_name: Peptic Ulcer


subject: UMLS:C3536872

subject_name: Histamine-2 Receptor Antagonist [EPC]


subject: UMLS:C5828752

object_name: kidney disorder


subject: CHEBI:38545

subject_name: Rosuvastatin

object_name: abdominal obesity-metabolic syndrome


subject: CHEBI:38545

object_name: metabolic syndrome X


subject: PUBCHEM.COMPOUND:11306691

subject_name: rac-Sitagliptin


subject: PUBCHEM.COMPOUND:11306691


subject: CHEBI:40237

subject_name: Sitagliptin


subject: CHEBI:40237


subject: CHEBI:9434

subject_name: Telmisartan


subject: CHEBI:9434


subject: CHEMBL.COMPOUND:CHEMBL2108465

subject_name: GINGER


subject: CHEMBL.COMPOUND:CHEMBL2108465


subject: UNII:C5529G5JPQ

subject_name: ginger extract


subject: UNII:C5529G5JPQ


subject: UMLS:C1950971

subject_name: Arjun


subject: UMLS:C1950971


subject: UNII:BLP1XA3FZA

subject_name: Venglustat

object_name: Fabry disease


subject: UMLS:C5706307

subject_name: Bimuno


subject: UMLS:C5706307


subject: UMLS:C4725626

subject_name: Anti-BCMA/PBD ADC MEDI2228

object_name: Relapsed/refractory multiple myeloma


subject: CHEBI:35181


subject: CHEBI:18198

subject_name: 4-amino-4-deoxychorismic acid


subject: CHEBI:157780

subject_name: S-Cysteinosuccinic acid


subject: PR:000022058

subject_name: biodegradative arginine decarboxylase


subject: PR:000007791

subject_name: acidic amino acid decarboxylase GADL1


subject: PR:000023971

subject_name: biosynthetic arginine decarboxylase


subject: UniProtKB:Q7NSA6

subject_name: ADC_CHRVO Acetoacetate decarboxylase (sprot)


subject: PR:000032161

subject_name: antizyme inhibitor 2


subject: UniProtKB:D4A693

subject_name: AZIN2_RAT Antizyme inhibitor 2 (sprot)


subject: UMLS:C4704928

subject_name: Antibody-Drug Conjugates


subject: CHEBI:31898

subject_name: Nedaplatin

object_name: non-small cell lung carcinoma


subject: CHEMBL.COMPOUND:CHEMBL3137685

subject_name: NEDAPLATIN


subject: UMLS:C0003442

subject_name: lymphocyte immune globulin, anti-thymocyte globulin

object_name: adult acute myeloid leukemia


subject: UMLS:C0003442

object_name: childhood acute myeloid leukemia


subject: UMLS:C0003442

object_name: acute myeloid leukemia


subject: UMLS:C0003442

object_name: myeloid leukemia


subject: CHEBI:201431

subject_name: Cyclosporin H


subject: CHEBI:201431


subject: CHEBI:201431


subject: CHEBI:4031

subject_name: Cyclosporine


subject: CHEBI:4031


subject: CHEBI:4031


subject: CHEBI:18246

subject_name: Cellulose

object_name: leukemia


subject: CHEBI:18246

object_name: childhood leukemia


subject: CHEBI:18246


subject: CHEBI:18246


subject: CHEBI:18246


subject: CHEBI:18246


subject: CHEBI:135765

subject_name: Methylprednisolone hemisuccinate


subject: CHEBI:135765


subject: CHEBI:135765


subject: CHEBI:135765


subject: CHEBI:135765


subject: CHEBI:135765


subject: CHEBI:6888

subject_name: Methylprednisolone


subject: CHEBI:6888


subject: CHEBI:6888


subject: CHEBI:6888


subject: CHEBI:168396

subject_name: Mycophenolic acid


subject: CHEBI:168396


subject: CHEBI:168396


subject: CHEBI:8764

subject_name: Mycophenolate mofetil


subject: CHEBI:8764


subject: CHEBI:8764


subject: CHEBI:167450

subject_name: Monomethyl fumarate


subject: CHEBI:167450


subject: CHEBI:167450


subject: CHEBI:167450


subject: PUBCHEM.COMPOUND:10408902

subject_name: Amibegron

object_name: endogenous depression


subject: PUBCHEM.COMPOUND:10408902

object_name: major depressive disorder


subject: UMLS:C5690659


subject: UMLS:C5690659


subject: GTOPDB:8357

subject_name: donanemab

object_name: Alzheimer disease type 1


subject: GTOPDB:8357

object_name: Alzheimer disease


subject: GTOPDB:8357

object_name: brain disorder


subject: GTOPDB:8357

object_name: CNS disorder


subject: GTOPDB:8357

object_name: Cognitive impairment


subject: GTOPDB:8357

object_name: Presenile dementia


subject: GTOPDB:8357

object_name: dementia


subject: UNII:1ADB65P1KK

subject_name: DONANEMAB


subject: UNII:1ADB65P1KK


subject: UNII:1ADB65P1KK


subject: UNII:1ADB65P1KK


subject: UNII:1ADB65P1KK


subject: UNII:1ADB65P1KK


subject: UNII:1ADB65P1KK


subject: UMLS:C5237999


subject: UMLS:C5237999


subject: UMLS:C5237999


subject: UMLS:C5237999


subject: UMLS:C5237999


subject: UMLS:C5237999


subject: UMLS:C5237999


subject: UMLS:C2352547

object_name: type 2 diabetes mellitus


subject: CHEBI:9150

subject_name: Simvastatin

object_name: plasma cell myeloma


subject: CHEBI:7915

subject_name: Pantoprazole

object_name: psychosis


subject: PUBCHEM.COMPOUND:136171075

subject_name: Folfirinox Regimen

object_name: Pancreatic cancer non-resectable


subject: PUBCHEM.COMPOUND:136171075

object_name: Effects of chemotherapy


subject: CHEBI:17754

subject_name: Glycerin

object_name: atrial septal defect


subject: UMLS:C1550506

subject_name: product - ParticipationType

object_name: Injury of musculoskeletal system


subject: UMLS:C5848411

subject_name: CDK4/6 Inhibitor G1T38

object_name: lung cancer


subject: UMLS:C5848411

object_name: lung neoplasm


subject: UMLS:C5848411

object_name: lung carcinoma


subject: UMLS:C5848411

object_name: non-small cell lung carcinoma


subject: UNII:2S9ZZM9Q9V

subject_name: Bevacizumab

object_name: malignant soft tissue neoplasm


subject: UNII:2S9ZZM9Q9V

object_name: sarcoma


subject: UMLS:C4744992

subject_name: Factor B Inhibitor LNP023

object_name: glomerulonephritis


subject: CHEBI:229652

subject_name: Iptacopan


subject: PUBCHEM.COMPOUND:633097

subject_name: Kenalog

object_name: osteoarthritis, knee


subject: CHEBI:9667

subject_name: Triamcinolone


subject: CHEBI:35475

subject_name: non-steroidal anti-inflammatory drug

object_name: rheumatoid arthritis


subject: UMLS:C0003211

subject_name: Anti-Inflammatory Agents, Non-Steroidal


subject: UMLS:C3536840

subject_name: Nonsteroidal Anti-inflammatory Drug [EPC]


subject: CHEBI:3766

subject_name: Clozapine

object_name: Psychotic disorder due to a general medical condition


subject: CHEBI:3766

object_name: childhood-onset schizophrenia


subject: CHEBI:94534

subject_name: olanzapine


subject: CHEBI:94534


subject: CHEBI:94534


subject: MESH:D000077325

subject_name: Ringer's Lactate

object_name: Intraoperative Complication


subject: CHEBI:133017

subject_name: Pimavanserin

object_name: schizophrenia


subject: CHEBI:151315

subject_name: Heparin

object_name: acute respiratory distress syndrome


subject: CHEBI:151315

object_name: acute lung injury


subject: KEGG.COMPOUND:C00374


subject: KEGG.COMPOUND:C00374


subject: KEGG.COMPOUND:C00374


subject: MESH:D000451

subject_name: Mineralocorticoid Receptor Antagonists

object_name: Conn's syndrome


subject: MESH:D000451

object_name: primary aldosteronism due to bilateral adrenal hyperplasia


subject: MESH:D000451

object_name: primary aldosteronism due to aldosterone producing adenoma


subject: UMLS:C1579268


subject: UMLS:C1579268


subject: UMLS:C1579268


subject: CHEBI:91872

object_name: liver cancer


subject: CHEBI:91872

object_name: liver neoplasm


subject: CHEBI:91872

object_name: Adult Liver Carcinoma


subject: CHEBI:91872

object_name: liver carcinoma


subject: CHEBI:28748

subject_name: Doxorubicin


subject: CHEBI:28748


subject: CHEBI:194095

subject_name: mitomycin C(1-)


subject: CHEBI:194095


subject: CHEBI:194095


subject: CHEBI:194095


subject: CHEBI:27504

subject_name: Mitomycin


subject: CHEBI:27504


subject: CHEBI:27504


subject: CHEBI:27504


subject: UMLS:C4287727

object_name: High grade glioma


subject: UMLS:C4287727

object_name: malignant glioma


subject: UMLS:C4287727

object_name: Childhood Brain Neoplasm


subject: UMLS:C4287727

object_name: Childhood Central Nervous System Neoplasm


subject: UMLS:C4287727

object_name: childhood brain stem neoplasm


subject: UMLS:C4287727

object_name: diffuse midline glioma, H3 K27M-mutant


subject: UMLS:C4287727

object_name: Spinal Neoplasm


subject: UMLS:C4287727

object_name: childhood spinal cord tumor


subject: UMLS:C4287727

object_name: Adult Spinal Cord Neoplasm


subject: UMLS:C4287727

object_name: childhood choroid plexus carcinoma


subject: UMLS:C4287727

object_name: pineocytoma


subject: UMLS:C4287727

object_name: Adult Pineocytoma


subject: CHEBI:84094

subject_name: testosterone sulfate

object_name: testosterone measurement


subject: UMLS:C4721537

subject_name: Therapeutic Testosterone


subject: CHEBI:17347

subject_name: Testosterone


subject: MESH:D007166

subject_name: Immunosuppressive Agents

object_name: Post transplant Epstein-Barr virus associated lymphoproliferative disorder


subject: MESH:D007166

object_name: post-treatment Lyme disease syndrome


subject: UNII:5RV7T5BNMG

object_name: rheumatoid arthritis


subject: DRUGBANK:DB18899


subject: UNII:52CMI0WC3Y

subject_name: Atezolizumab

object_name: HER2 positive breast carcinoma


subject: UNII:52CMI0WC3Y

object_name: HER2 positive bladder cancer


subject: UNII:52CMI0WC3Y

object_name: HER2-positive gastric cancer


subject: UMLS:C3827082


subject: UMLS:C3827082


subject: UMLS:C3827082


subject: CHEBI:136048

subject_name: Vonoprazan

object_name: Heartburn


subject: UNII:4F4X42SYQ6

subject_name: Rituximab

object_name: metastatic melanoma


subject: UMLS:C0295415

subject_name: rituximab


subject: UNII:28X28X9OKV

subject_name: Durvalumab

object_name: Non-small cell lung cancer stage III


subject: UMLS:C3641122


subject: CHEBI:17303

subject_name: Morphine

object_name: Injury of musculoskeletal system


subject: CHEBI:5855

subject_name: Ibuprofen


subject: UNII:O43472U9X8

subject_name: Obinutuzumab

object_name: mantle cell lymphoma


subject: UNII:AIS8N3O50B

subject_name: Seltorexant

object_name: major depressive disorder


subject: MESH:C000716647

object_name: nephrotic syndrome


subject: MESH:C000716647

object_name: Nephrotic Syndrome, CTCAE


subject: CHEBI:64073

object_name: Wolfram syndrome


subject: CHEBI:64073

object_name: Diabetes mellitus associated with genetic syndrome


subject: UNII:9P1872D4OL

subject_name: Exenatide


subject: UNII:9P1872D4OL


subject: CHEBI:35176

subject_name: Zinc sulfate

object_name: mucositis


subject: PUBCHEM.COMPOUND:155543961

subject_name: LIRAGLUTIDE

object_name: Androgen excess


subject: UMLS:C1099192


subject: CHEMBL.COMPOUND:CHEMBL2108661

subject_name: VEHICLE

object_name: psoriasis


subject: CHEBI:61057

subject_name: TACROLIMUS

object_name: autoimmune hepatitis


subject: PUBCHEM.COMPOUND:5372


subject: CHEBI:61049

subject_name: Tacrolimus


subject: CHEBI:75179

subject_name: Trifluridine

object_name: colorectal carcinoma


subject: CHEBI:90879

subject_name: Tipiracil


subject: DRUGBANK:DB08937


subject: CHEBI:90876

subject_name: Lonsurf


subject: CHEBI:90863

subject_name: Sonidegib

object_name: basal cell carcinoma


subject: CHEBI:90863

object_name: skin basal cell carcinoma


subject: CHEBI:3441

subject_name: Carvedilol

object_name: Hemorrhage


subject: CHEBI:16480

subject_name: Nitric Oxide

object_name: Hypoxemia


subject: CHEBI:16480

object_name: Hypoxia, CTCAE


subject: PUBCHEM.COMPOUND:11332179

subject_name: pasireotide

object_name: ectopic ACTH secretion syndrome


subject: UMLS:C0795657

subject_name: Aralast

object_name: HIV infection


subject: PR:000033658

subject_name: arabinose 5-phosphate isomerase GutQ


subject: UMLS:C0002191

subject_name: alpha 1-antitrypsin


subject: CHEBI:193860

subject_name: Chymopapain


subject: UNII:80YS8O1MBS

subject_name: CISATRACURIUM BESYLATE

object_name: acute respiratory distress syndrome


subject: UNII:80YS8O1MBS

object_name: adult acute respiratory distress syndrome


subject: CHEBI:140621

subject_name: Cisatracurium


subject: CHEBI:140621


subject: UNII:WP58SVM6R4

subject_name: Laronidase

object_name: mucopolysaccharidosis type 1


subject: UNII:WP58SVM6R4

object_name: Hurler-Scheie syndrome


subject: UNII:WP58SVM6R4

object_name: Hurler syndrome


subject: UNII:WP58SVM6R4

object_name: Scheie syndrome


subject: CHEBI:9927

subject_name: Valsartan

object_name: Left Ventricular Hypertrophy by ECG Finding


subject: UMLS:C4086546

subject_name: Liposomal Bupivacaine

object_name: Shoulder pain


subject: CHEBI:3901

subject_name: Tetracosactide

object_name: adrenocortical insufficiency


subject: CHEBI:3901

object_name: Adrenal Insufficiency, CTCAE


subject: CHEBI:3901

object_name: Cirrhosis


subject: CHEBI:3901

object_name: liver cirrhosis


subject: CHEBI:6933

subject_name: Midodrine

object_name: Hypothermia due to exposure


subject: CHEBI:6933

object_name: Hypothermia


subject: CHEBI:6933

object_name: Hypothermia, CTCAE


subject: CHEBI:6933

object_name: quadriplegia


subject: CHEBI:6933

object_name: mild neurocognitive disorder


subject: CHEBI:6933

object_name: mild cognitive impairment


subject: UNII:52CMI0WC3Y

subject_name: Atezolizumab

object_name: Early Stage Breast Carcinoma


subject: UMLS:C3827082


subject: UMLS:C3536964

subject_name: rotavirus, live, tetravalent vaccine

object_name: Rotavirus infection


subject: CHEBI:7507

subject_name: Framycetin

object_name: Postoperative Complications


subject: CHEBI:7507

object_name: Surgical Wound Infection


subject: CHEBI:7507

object_name: colorectal cancer


subject: CHEBI:7507

object_name: colorectal carcinoma


subject: CHEBI:7507

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: UNII:L500PR95QA

subject_name: METRONIDAZOLE PHOSPHATE


subject: UNII:L500PR95QA


subject: UNII:L500PR95QA


subject: UNII:L500PR95QA


subject: UNII:L500PR95QA


subject: CHEBI:6909

subject_name: Metronidazole


subject: CHEBI:6909


subject: CHEBI:6909


subject: CHEBI:6909


subject: CHEBI:6909


subject: CHEBI:38940

subject_name: Sunitinib

object_name: exocrine pancreatic carcinoma


subject: CHEBI:38940

object_name: malignant pancreatic neoplasm


subject: CHEBI:231614

subject_name: Nivolumab

object_name: head and neck squamous cell carcinoma


subject: UMLS:C2346820


subject: CHEBI:46859

subject_name: Polidocanol

object_name: internal hemorrhoid


subject: PUBCHEM.COMPOUND:126961754

subject_name: Opioids

object_name: Critical Illness


subject: PUBCHEM.COMPOUND:126961754

object_name: substance withdrawal syndrome


subject: CHEBI:35482

subject_name: opioid analgesic


subject: CHEBI:35482


subject: UMLS:C0242402


subject: UMLS:C0242402


subject: UNII:MF4P7VQ2K8

subject_name: TAVOKINOGENE TELSEPLASMID

object_name: melanoma


subject: UNII:P8DD8KX4O4

subject_name: TOFOGLIFLOZIN

object_name: type 2 diabetes mellitus


subject: CHEBI:136041

subject_name: Tofogliflozin


subject: UMLS:C5446586

subject_name: P2RX3 Antagonist BAY 1817080

object_name: Endometriosis related pain


subject: CHEBI:6931

subject_name: Midazolam

object_name: Urinary Urgency


subject: CHEBI:6931


subject: UMLS:C0212182

object_name: Depressed mood


subject: GTOPDB:4934

subject_name: G-CSF

object_name: habitual spontaneous abortion


subject: UNII:PVI5M0M1GW

subject_name: Filgrastim


subject: PR:000005932

subject_name: granulocyte colony-stimulating factor


subject: CHEBI:8871

subject_name: Risperidone

object_name: schizoaffective disorder


subject: CHEBI:8871

object_name: schizophrenia 18


subject: GTOPDB:9592

subject_name: tislelizumab

object_name: superficial urinary bladder carcinoma


subject: CHEMBL.COMPOUND:CHEMBL4297840

subject_name: TISLELIZUMAB


subject: UMLS:C4053664


subject: CHEBI:39548

subject_name: Atorvastatin

object_name: Hyperintensity of cerebral white matter on MRI


subject: CHEBI:39548

object_name: neurodegenerative disease


subject: CHEBI:39548

object_name: vascular dementia


subject: CHEBI:39548

object_name: Mental deterioration


subject: CHEBI:39548

object_name: Cognitive impairment


subject: CHEBI:39548

object_name: Mixed Dementias


subject: CHEBI:91083

subject_name: Romiplostim

object_name: Chemotherapy-Induced Thrombocytopenia


subject: UMLS:C1505595


subject: CHEBI:6933

subject_name: Midodrine

object_name: orthostatic hypotension


subject: CHEBI:6933

object_name: spinal cord injury


subject: UNII:3DGD69C6PV

subject_name: brigatinib

object_name: lung cancer


subject: UNII:3DGD69C6PV

object_name: lung neoplasm


subject: UNII:3DGD69C6PV

object_name: lung carcinoma


subject: UNII:3DGD69C6PV

object_name: Non-small cell lung cancer stage IIIB


subject: UNII:3DGD69C6PV

object_name: Metastatic non-small cell lung cancer


subject: UNII:3DGD69C6PV

object_name: non-small cell lung carcinoma


subject: CHEBI:94807

subject_name: Nitazoxanide

object_name: HIV infection


subject: CHEBI:94807

object_name: HCV coinfection


subject: CHEBI:68534

subject_name: Enzalutamide

object_name: Metastatic malignant neoplasm to bone


subject: CHEBI:84500

subject_name: varenicline

object_name: Parkinson disease


subject: CHEBI:60802

subject_name: ropivacaine

object_name: cholecystitis


subject: CHEBI:60802

object_name: Cholecystitis, CTCAE 3.0


subject: CHEBI:60802

object_name: Cholecystitis, CTCAE 5.0


subject: UNII:MRL3739G66

subject_name: Dotatate

object_name: pancreatic endocrine carcinoma


subject: UNII:MRL3739G66

object_name: Neuroendocrine carcinoma of pancreas


subject: PR:000002327

subject_name: gelsolin isoform 1

object_name: metabolic dysfunction-associated steatotic liver disease


subject: PR:000002327


subject: UMLS:C4725919

subject_name: MEK Inhibitor SHR 7390

object_name: Metastatic castration-resistant prostate cancer


subject: CHEBI:85078

subject_name: Dapagliflozin

object_name: Complication of hemodialysis


subject: CHEBI:24866

subject_name: salt


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate

object_name: PROSTATE CANCER ADENOCARCINOMA IN SITU


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: UMLS:C5761796

subject_name: GVAX


subject: CHEBI:74705

subject_name: Met-Leu

object_name: glaucoma


subject: CHEBI:74705

object_name: Glaucoma, CTCAE


subject: PR:000009425

subject_name: killer cell lectin-like receptor subfamily F member 1


subject: PR:000009425


subject: PR:000016318

subject_name: thrombopoietin


subject: PR:000016318


subject: PR:000022848

subject_name: guanosine-inosine kinase


subject: PR:000022848


subject: UniProtKB:P0AEW6

subject_name: INGK_ECOLI Guanosine-inosine kinase (sprot)


subject: UniProtKB:P0AEW6


subject: CHEBI:32139

object_name: cardiac arrest


subject: CHEBI:32139

object_name: Cardiac Arrest, CTCAE


subject: CHEBI:134716

subject_name: Brexpiprazole

object_name: schizophrenia


subject: PUBCHEM.COMPOUND:3663

subject_name: hypericin

object_name: mycosis fungoides


subject: PUBCHEM.COMPOUND:3663

object_name: primary cutaneous T-cell non-Hodgkin lymphoma


subject: PUBCHEM.COMPOUND:3663

object_name: primary cutaneous T-cell lymphoma


subject: CHEBI:5835

subject_name: Hypericin


subject: CHEBI:5835


subject: CHEBI:5835


subject: CHEBI:36088

subject_name: thromboxanes A

object_name: traumatic encephalopathy


subject: CHEBI:36088

object_name: traumatic brain injury


subject: CHEBI:95346

subject_name: Atovaquone

object_name: pneumocystosis


subject: CHEBI:95346

object_name: HIV infection


subject: GTOPDB:8458

subject_name: otelixizumab

object_name: type 1 diabetes mellitus 1


subject: GTOPDB:8458

object_name: type 1 diabetes mellitus


subject: UNII:I5HF2X04PB


subject: UNII:I5HF2X04PB


subject: UMLS:C2935224


subject: UMLS:C2935224


subject: CHEMBL.COMPOUND:CHEMBL2108570

subject_name: ABOBOTULINUMTOXINA

object_name: Post-Traumatic Headache


subject: UMLS:C2729275

subject_name: INJECTION, ABOBOTULINUMTOXINA, 5 UNITS


subject: CHEBI:31596

subject_name: Febuxostat

object_name: gout


subject: UMLS:C0962969

subject_name: RAD 001

object_name: renal cell carcinoma


subject: PUBCHEM.COMPOUND:70789204

subject_name: Everolimus


subject: CHEBI:31198

subject_name: Ambroxol hydrochloride

object_name: Parkinson disease


subject: CHEBI:31198

object_name: GBA gene mutation


subject: UNII:CC995ZMV90

subject_name: AMBROXOL HYDROCHLORIDE


subject: UNII:CC995ZMV90


subject: CHEBI:135590

subject_name: Ambroxol


subject: CHEBI:135590


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate

object_name: vasculitis


subject: CHEBI:4026

object_name: Vasculitis, CTCAE


subject: CHEBI:4026

object_name: microscopic polyangiitis


subject: CHEBI:4026

object_name: eosinophilic granulomatosis with polyangiitis


subject: CHEBI:4026

object_name: polyarteritis nodosa


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:2948

subject_name: Azathioprine


subject: CHEBI:2948


subject: CHEBI:2948


subject: CHEBI:2948


subject: CHEBI:2948

object_name: granulomatosis with polyangiitis


subject: CHEBI:2948


subject: CHEBI:8382

subject_name: Prednisone


subject: CHEBI:8382


subject: CHEBI:8382


subject: CHEBI:8382


subject: CHEBI:8382


subject: CHEBI:8382


subject: CHEBI:6888

subject_name: Methylprednisolone


subject: CHEBI:6888


subject: CHEBI:6888


subject: CHEBI:6888


subject: CHEBI:6888


subject: CHEBI:6888


subject: UMLS:C1831874

object_name: Metastatic castration-resistant prostate cancer


subject: PUBCHEM.COMPOUND:3367

object_name: MALT lymphoma


subject: CHEBI:63599

subject_name: Fludarabine


subject: PUBCHEM.COMPOUND:131769963

subject_name: Digoxigenin monodigitoxoside

object_name: kidney neoplasm


subject: UNII:5XYK65KIGD


subject: CHEBI:50924

subject_name: Sorafenib


subject: CHEBI:3757

subject_name: Clonidine

object_name: Congenital postural scoliosis


subject: CHEBI:3757

object_name: scoliosis


subject: CHEBI:3757

object_name: Scoliosis, CTCAE